rfhg_157785.1

Basic information about the TSS

---

TSS ID: rfhg_157785.1 Species: human Chr: chr12		Start: 123272102 End: 123272112 Strand: -
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D2618330,EH38E1652348)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: AF006484:-28 GeneID: 8099 HGNC/MGI_ID: HGNC:14002 UniProt_ID: Nearer transcript ids and distances: NR_073007.2:-128 ENST00000544658.5:-222 ENST00000261692.7:246 NM_004642.4:246 AB006077:406 BC034717:463 DQ891281:484 KJ892469:484 DQ894468:484 view more...

Gene_name: cyclin dependent kinase 2 associated protein 1 Gene_symbol: CDK2AP1 Gene_synonyms: DOC1 DORC1 ST19 doc-1 p12DOC-1 Gene_source: HGNC:14002

TATA-Box annotation

---

Distance to TSS:	133
Nearest PromoterID:	NR_073007
Entrez ID:	8099
Nearest Unigene:	Hs.433201
Nearest Refseq:	NM_004642
Nearest Ensembl:	ENSG00000111328
Gene Name:	cyclin dependent kinase 2 associated protein 1
Gene Alias:	DOC1|DORC1|ST19|doc-1|p12DOC-1
Gene Type:	protein-coding
CpG%:	0.100000
GC%:	0.454545
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@CDK2AP1 p2@CDK2AP1 p3@CDK2AP1 p4@CDK2AP1 p5@CDK2AP1 p6@CDK2AP1 p7@CDK2AP1 p8@CDK2AP1 p9@CDK2AP1 p10@CDK2AP1
Sample		p1@CDK2AP1	p2@CDK2AP1	p3@CDK2AP1	p4@CDK2AP1	p5@CDK2AP1	p6@CDK2AP1	p7@CDK2AP1	p8@CDK2AP1	p9@CDK2AP1	p10@CDK2AP1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	33.70	5.45	4.48	3.31	1.36	1.75	0.00	2.14	0.19	0.00
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	32.98	4.86	4.65	1.01	3.44	1.21	0.00	2.02	0.20	0.00
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	38.00	4.82	2.70	2.89	1.74	1.93	0.00	0.96	0.96	0.00
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	39.92	3.74	3.74	2.49	1.87	1.46	0.00	2.49	0.42	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	33.97	5.17	4.05	2.02	1.57	0.00	0.00	2.47	0.22	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	34.89	2.71	4.07	2.33	0.39	1.74	0.00	1.16	0.78	0.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	49.02	7.41	6.54	2.83	3.92	2.40	0.00	4.36	0.65	0.00
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	37.30	6.30	4.36	1.70	3.88	1.70	0.00	1.94	0.48	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	44.45	5.34	5.56	2.56	2.78	1.71	0.00	0.64	0.43	0.00
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	28.40	4.06	2.32	1.16	3.48	1.16	0.00	1.16	2.32	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	19.81	5.66	4.45	1.62	2.83	1.62	0.00	0.81	0.81	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	18.29	3.25	1.63	1.22	4.07	1.22	0.00	3.25	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	58.51	1.77	2.10	0.48	0.16	0.16	0.00	0.81	0.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	45.11	1.35	0.75	0.45	0.45	0.75	0.00	0.30	0.30	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	55.33	2.20	1.76	0.44	0.00	0.44	0.00	0.44	0.88	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	46.02	3.27	0.50	1.76	0.00	0.25	0.00	0.25	1.01	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	48.05	1.53	0.87	0.87	0.66	0.66	0.00	1.09	0.87	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	38.81	1.27	0.00	0.42	0.00	0.42	0.00	0.00	2.53	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	29.86	2.67	1.07	0.00	0.00	0.00	0.00	1.07	0.53	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	45.58	1.65	1.35	1.50	0.00	0.45	0.00	0.45	0.45	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	48.65	1.60	1.87	1.20	0.40	0.80	0.00	0.80	0.27	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	41.08	2.42	0.69	0.35	0.35	0.00	0.00	0.52	0.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	46.66	2.97	1.68	0.26	0.52	0.52	0.00	1.55	0.78	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	54.84	1.21	0.97	0.49	0.49	0.00	0.00	0.97	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	43.34	1.81	0.77	0.77	1.03	0.00	0.00	0.26	0.77	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	38.61	3.17	0.95	0.63	0.32	0.95	0.00	0.95	1.27	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	34.07	2.75	2.75	0.00	1.65	0.00	0.00	0.55	0.55	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	53.04	2.36	1.41	0.94	0.71	0.24	0.00	1.18	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	45.07	3.23	1.62	0.97	0.16	0.16	0.00	0.65	0.65	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	55.38	2.71	0.54	0.72	0.18	0.36	0.00	0.54	0.36	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	49.61	2.51	1.67	0.63	0.00	0.63	0.00	1.05	0.84	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	45.52	4.49	0.78	0.59	0.00	0.20	0.00	0.59	1.17	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	43.89	2.53	0.63	0.00	0.00	0.42	0.00	1.06	1.06	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	31.67	3.13	0.82	0.16	0.16	0.82	0.00	0.49	0.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	54.41	2.99	1.31	0.37	0.75	0.37	0.00	0.93	1.12	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	56.72	1.92	1.53	1.72	0.77	0.00	0.00	0.57	1.15	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	55.59	5.52	1.84	1.84	0.41	0.61	0.00	0.82	0.61	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	47.55	3.02	1.01	1.01	0.60	0.20	0.00	0.81	1.41	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	53.21	5.13	1.08	0.27	0.00	1.08	0.00	0.81	0.81	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	54.25	3.84	1.20	1.20	0.24	0.00	0.00	0.72	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	51.52	2.12	0.94	0.94	0.24	0.94	0.00	0.00	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	35.57	1.90	0.73	0.29	0.44	1.17	0.00	0.73	0.29	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	58.00	3.80	1.27	0.84	0.21	0.63	0.00	1.05	0.21	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	56.82	3.85	1.57	0.87	0.70	0.00	0.00	1.40	0.87	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	55.61	4.42	1.41	1.00	0.60	0.40	0.00	0.40	1.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	59.32	3.02	0.93	1.16	0.00	1.16	0.00	0.93	0.93	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	71.73	5.76	1.20	0.96	0.72	0.72	0.00	1.20	0.48	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	61.99	3.87	2.09	1.19	0.30	0.30	0.00	0.60	0.60	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	69.66	3.11	1.20	1.68	0.24	0.72	0.00	1.68	1.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	59.85	4.25	1.01	1.21	0.40	0.61	0.00	1.21	1.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	46.93	5.12	1.02	1.02	0.20	0.61	0.00	2.05	0.82	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	64.49	4.89	2.00	0.67	0.00	0.22	0.00	0.89	1.78	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	69.96	0.00	0.00	0.00	0.00	13.99	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	81.26	8.16	1.77	0.35	0.71	0.35	0.00	0.35	2.48	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	74.89	10.27	0.66	0.66	0.66	0.66	0.00	0.00	2.65	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	30.20	4.19	0.00	1.68	0.00	2.52	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	34.44	3.67	0.00	0.00	0.00	1.38	0.00	0.46	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	85.89	9.08	0.97	0.97	1.62	0.32	0.00	0.00	1.94	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	111.77	7.07	0.64	0.32	0.96	0.96	0.00	0.00	0.64	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	43.69	4.40	0.31	1.57	0.31	0.63	0.00	0.31	0.31	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	105.76	9.17	0.71	0.71	0.71	1.41	0.00	0.00	1.41	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	107.67	11.78	1.12	0.56	0.56	0.56	0.00	0.56	0.56	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	28.66	1.59	1.59	2.39	0.00	0.80	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	56.40	4.42	0.68	0.68	0.00	0.00	0.00	1.02	0.34	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	126.07	5.20	0.97	1.95	0.97	0.32	0.00	0.00	1.62	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	129.57	7.10	1.42	0.71	1.06	1.06	0.00	0.00	2.48	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	0.00	0.00	0.00	16.16	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	55.28	7.90	0.00	0.00	0.00	7.90	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	112.13	10.73	0.98	1.95	0.49	0.49	0.00	1.46	1.46	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	110.08	7.93	0.50	1.98	0.50	0.99	0.00	0.50	0.50	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	104.14	10.32	1.41	0.94	0.47	0.94	0.00	0.47	0.94	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	66.57	5.63	0.66	0.00	0.33	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	121.88	7.73	0.31	0.62	0.31	0.62	0.00	0.93	0.62	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	124.44	6.73	1.22	0.61	0.61	0.31	0.00	0.92	0.00	0.00
Adipocyte - breast, donor1	11376-118A8	162.98	12.83	3.01	2.38	2.69	0.95	0.16	0.79	1.43	0.00
Adipocyte - breast, donor2	11327-117E4	148.88	14.44	3.21	1.44	3.05	0.96	0.00	1.44	1.12	0.00
Adipocyte - omental, donor1	11473-119C6	171.50	12.34	2.93	2.04	3.82	0.89	0.00	0.51	1.53	0.00
Adipocyte - omental, donor2	11474-119C7	102.41	9.72	0.75	1.49	0.75	0.75	0.00	0.00	0.75	0.00
Adipocyte - omental, donor3	11475-119C8	70.67	11.05	1.67	2.34	1.00	0.33	0.00	0.33	0.33	0.00
Adipocyte - perirenal, donor1	11476-119C9	116.75	15.95	3.83	0.64	0.00	0.00	0.00	0.64	1.91	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	63.77	3.30	1.10	2.20	0.00	0.00	0.00	0.00	1.10	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	74.07	6.77	0.90	0.90	1.35	0.45	0.00	0.45	1.35	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	65.34	1.91	0.70	0.70	0.17	0.17	0.00	0.35	0.52	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	147.66	6.06	2.15	1.76	0.98	0.78	0.00	0.59	3.13	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	89.31	6.18	1.29	1.29	0.51	0.77	0.00	0.51	0.77	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	99.24	4.46	3.62	0.84	1.12	1.12	0.00	1.12	2.23	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	71.71	6.47	1.18	1.76	0.59	1.76	0.00	0.59	1.18	0.59
Adipocyte differentiation, day08, donor1	13020-139D5	89.36	3.78	1.77	0.97	0.48	0.32	0.00	0.24	1.45	0.00
Adipocyte differentiation, day08, donor2	13023-139D8	56.48	4.52	0.97	0.00	0.65	0.00	0.00	0.32	1.61	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	52.25	1.07	0.53	0.00	0.53	0.53	0.00	0.00	2.13	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	47.85	2.78	1.11	0.00	0.00	0.56	0.00	1.11	0.56	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	59.89	7.07	1.25	1.66	0.00	0.00	0.00	0.42	0.00	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	49.73	3.27	1.51	0.25	0.00	0.50	0.00	0.00	0.25	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	48.11	3.93	0.65	0.33	0.65	0.33	0.00	0.33	1.31	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	38.36	1.22	0.30	0.30	0.30	0.30	0.00	0.30	1.83	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	158.23	11.05	2.43	1.99	3.09	0.88	0.00	3.31	0.44	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	71.00	11.83	3.94	2.51	0.72	0.36	0.00	2.51	0.72	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	55.11	5.99	1.20	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	130.61	13.13	3.60	1.08	0.90	0.72	0.00	0.72	0.72	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	107.10	13.39	3.35	0.00	1.67	0.00	0.00	3.35	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	160.45	18.90	3.49	2.05	1.03	0.21	0.00	1.64	0.21	0.00
Anulus Pulposus Cell, donor1	11248-116E6	118.09	8.93	1.49	0.46	1.26	1.37	0.34	0.57	1.14	0.34
Anulus Pulposus Cell, donor2	11463-119B5	62.21	10.78	0.98	0.73	0.73	0.00	0.24	0.24	0.24	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	84.92	14.83	0.90	0.90	1.35	0.45	0.00	0.90	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	113.31	15.63	2.60	0.87	2.60	1.30	0.00	0.87	1.30	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	128.41	32.10	2.14	0.00	4.28	2.14	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	92.96	11.06	1.20	0.60	1.49	2.09	0.00	0.60	0.30	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	80.94	20.23	0.00	1.26	2.53	2.53	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	112.87	19.14	0.00	2.64	1.32	1.32	0.00	1.32	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	97.14	11.05	1.30	0.65	1.62	0.65	0.00	1.62	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	103.88	14.08	0.97	0.00	1.94	0.97	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	105.12	17.82	0.59	1.78	1.19	2.38	0.00	0.00	0.59	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	96.04	13.18	1.13	0.75	1.88	1.88	0.00	0.38	0.38	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	97.97	10.89	1.45	2.18	0.73	1.45	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	121.62	10.03	1.25	1.25	2.51	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	176.10	18.45	3.62	1.48	3.46	3.46	0.00	0.49	0.33	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	105.09	6.82	1.36	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	154.56	15.23	1.36	1.06	1.96	1.51	0.00	0.45	0.15	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	82.51	17.68	2.14	0.00	3.75	0.54	0.00	1.07	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	126.96	14.93	1.89	0.76	3.21	1.13	0.00	0.76	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	126.16	17.37	1.07	1.07	1.87	1.60	0.00	0.80	0.27	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	90.72	12.68	1.95	1.95	0.00	0.98	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	106.32	11.44	2.16	1.16	1.99	1.00	0.00	0.33	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	117.67	26.42	1.20	0.00	2.40	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	53.10	17.70	0.00	3.54	3.54	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	121.96	11.32	1.72	1.89	1.37	2.40	0.00	0.69	0.69	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	96.48	16.78	0.00	4.19	12.58	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	93.69	10.19	1.46	0.97	1.46	1.94	0.00	1.94	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	110.42	15.94	1.14	1.90	1.90	0.38	0.00	0.76	1.14	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	92.06	21.80	2.42	0.00	1.21	2.42	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	92.35	14.82	2.28	0.00	1.71	2.85	0.00	0.57	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	121.85	15.82	0.86	1.28	1.28	1.50	0.00	0.21	0.43	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	128.53	15.49	0.52	0.77	1.03	0.52	0.00	0.26	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	84.46	10.32	1.41	0.00	2.35	1.41	0.00	0.94	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	138.27	15.11	0.32	1.61	1.93	1.29	0.00	0.64	0.64	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	112.01	16.41	0.71	1.43	0.71	2.14	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	74.29	16.38	1.17	2.34	1.17	1.17	0.00	0.00	0.58	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	105.07	10.84	1.20	0.90	0.90	0.90	0.00	1.20	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	133.05	17.82	1.19	2.38	3.56	2.38	0.00	1.19	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	87.47	19.33	0.00	0.51	0.51	2.54	0.00	1.02	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	107.99	11.97	2.04	1.53	2.04	1.02	0.00	0.76	0.25	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	107.38	14.61	1.91	0.64	1.27	1.91	0.00	0.64	0.64	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	93.21	15.97	1.73	0.43	2.16	0.43	0.00	0.86	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	117.49	12.70	2.12	0.85	2.12	1.06	0.00	0.85	0.21	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	121.50	17.11	0.87	0.00	3.19	1.45	0.00	0.58	0.29	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	97.31	14.17	1.89	0.00	0.94	0.94	0.00	2.83	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	124.09	13.39	1.36	1.70	0.51	1.86	0.00	0.51	0.34	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	113.50	16.21	0.00	0.00	0.00	0.00	0.00	2.32	2.32	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	107.74	10.56	0.00	2.11	6.34	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	109.56	12.86	1.50	0.86	2.36	0.43	0.00	0.43	0.86	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	117.93	18.05	1.20	1.80	3.01	1.20	0.00	0.60	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	79.46	13.85	0.73	2.19	1.46	0.73	0.00	1.46	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	120.23	10.11	1.61	0.92	1.84	2.07	0.00	0.46	0.23	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	89.26	12.75	0.00	0.00	0.00	2.55	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	148.73	12.46	0.76	0.25	2.03	1.53	0.00	0.25	0.51	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	125.31	14.86	0.83	1.03	2.89	1.24	0.00	0.41	0.21	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	124.54	13.46	1.53	0.92	1.84	1.53	0.00	1.22	0.31	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	87.00	15.77	0.96	0.96	1.91	0.96	0.00	0.96	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	122.62	15.74	1.33	0.89	2.88	1.11	0.00	0.89	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	112.91	25.94	0.00	1.53	1.53	1.53	0.00	1.53	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	69.79	16.62	2.77	1.11	0.00	2.22	0.00	1.11	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	110.42	13.50	1.32	1.32	1.85	1.06	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	110.85	12.72	1.82	0.36	2.91	2.18	0.00	0.36	0.00	0.00
Astrocyte - cerebellum, donor1	11500-119F6	184.22	16.83	4.54	2.46	1.84	10.32	0.98	1.97	0.98	0.49
Astrocyte - cerebellum, donor2	11580-120F5	134.36	20.20	1.54	2.40	1.03	2.23	0.51	1.71	0.17	0.17
Astrocyte - cerebellum, donor3	11661-122F5	166.54	15.31	2.10	2.52	3.78	2.94	0.42	2.73	0.21	0.42
Astrocyte - cerebral cortex, donor1	11235-116D2	308.50	16.73	4.18	4.53	3.83	4.88	6.62	1.05	0.70	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	305.43	26.85	5.66	4.85	7.28	4.53	2.75	2.26	0.49	0.81
Astrocyte - cerebral cortex, donor3	11392-118C6	352.76	25.36	4.77	6.71	7.31	3.58	3.88	1.94	0.89	0.60
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	42.32	4.24	1.49	0.92	0.92	0.34	0.00	0.46	0.11	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	50.74	6.51	0.88	1.00	1.75	0.63	0.00	1.13	0.75	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	42.56	5.80	1.59	0.34	1.37	0.46	0.00	1.14	0.00	0.00
Basophils, donor1	12241-129G9	10.72	0.78	0.00	0.00	0.00	0.00	4.71	0.00	0.00	5.75
Basophils, donor2	12242-129H1	5.77	1.80	0.00	0.36	0.36	0.00	1.44	0.00	0.00	2.89
Basophils, donor3	12243-129H2	29.99	1.91	0.29	0.15	0.44	0.00	4.26	0.15	0.00	5.88
Bronchial Epithelial Cell, donor1	11511-119G8	60.58	3.67	1.08	0.65	0.00	0.43	0.00	0.22	0.86	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	65.83	3.66	1.37	0.46	0.00	0.00	0.00	0.46	0.46	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	57.39	7.17	14.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	64.02	6.90	2.51	0.63	1.88	0.00	0.00	0.63	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	57.39	7.90	1.87	1.04	0.42	0.00	0.00	1.04	0.83	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	46.29	4.61	0.69	0.23	0.00	0.46	0.00	0.92	0.23	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	58.66	4.86	0.36	0.18	0.72	0.54	0.00	0.36	0.00	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Burkitt's lymphoma cell line:RAJI	10476-106I8	9.32	0.70	0.00	0.00	0.23	0.00	0.00	0.00	0.00	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	73.55	7.67	2.24	2.24	3.84	2.24	9.27	1.60	0.64	4.48
CD133+ stem cells - cord blood derived, pool1	12223-129E9	165.47	20.68	0.00	20.68	0.00	0.00	51.71	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	10.71	0.00	0.00	0.00	0.00	0.00	4.51	0.00	0.00	5.64
CD14+ Monocytes, donor2	11305-117B9	16.33	0.74	0.56	0.37	0.19	0.00	2.23	0.19	0.19	5.57
CD14+ Monocytes, donor3	11381-118B4	11.42	1.54	0.22	0.00	0.44	0.00	3.29	0.00	0.00	5.93
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	65.95	1.13	1.13	1.13	0.00	0.57	0.57	0.28	2.26	0.28
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	33.74	1.14	0.76	0.38	0.00	0.00	0.76	0.00	0.76	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	69.36	2.63	1.97	1.64	0.66	0.99	0.66	0.99	2.63	0.99
CD14+ monocytes - mock treated, donor1	11863-125A9	15.03	1.73	0.29	0.14	0.14	0.00	1.30	0.14	0.14	2.31
CD14+ monocytes - mock treated, donor2	11873-125C1	6.94	0.91	0.30	0.91	0.30	0.00	2.11	0.00	0.00	0.91
CD14+ monocytes - mock treated, donor3	11883-125D2	16.82	0.95	0.24	0.24	0.00	0.00	3.08	0.00	0.00	2.13
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	7.53	0.67	0.17	0.17	0.17	0.17	1.51	0.00	0.17	1.17
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	7.45	0.28	0.00	0.00	0.28	0.00	2.21	0.00	0.00	1.10
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	9.92	0.74	0.00	0.00	0.25	0.25	3.22	0.00	0.00	1.74
CD14+ monocytes - treated with BCG, donor1	11860-125A6	9.40	0.20	0.00	0.00	0.00	0.00	1.96	0.00	0.00	2.94
CD14+ monocytes - treated with BCG, donor2	11870-125B7	9.44	1.25	0.36	0.18	0.36	0.18	2.49	0.00	0.00	1.42
CD14+ monocytes - treated with BCG, donor3	11880-125C8	14.58	1.96	0.00	0.00	0.44	0.87	4.13	0.00	0.00	3.92
CD14+ monocytes - treated with Candida, donor1	11868-125B5	5.85	0.47	0.00	0.00	0.00	0.00	1.87	0.00	0.00	2.34
CD14+ monocytes - treated with Candida, donor2	11878-125C6	6.34	1.06	0.00	0.00	0.00	0.00	3.17	0.53	0.00	3.17
CD14+ monocytes - treated with Candida, donor3	11888-125D7	12.20	1.11	0.00	0.00	0.00	0.00	3.33	0.00	0.00	4.44
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	11.45	1.64	0.30	0.00	0.30	0.00	0.74	0.00	0.00	2.53
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	4.79	1.20	0.40	0.20	0.40	0.00	1.20	0.00	0.00	2.20
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	10.20	1.25	0.00	0.00	0.00	0.00	2.29	0.21	0.00	4.37
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	5.95	1.14	0.46	0.23	0.00	0.00	1.14	0.46	0.46	1.37
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	7.01	0.68	0.23	0.00	0.23	0.23	1.58	0.00	0.00	2.71
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	10.04	0.87	0.44	0.00	0.00	0.00	0.87	0.00	0.00	1.75
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	9.95	0.54	0.27	0.00	0.00	0.00	1.88	0.00	0.00	1.34
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	14.65	2.09	0.17	0.17	0.35	0.00	2.09	0.17	0.00	2.62
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	23.99	2.10	0.84	0.42	0.00	0.00	3.79	0.42	0.00	4.63
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	6.25	0.92	0.00	0.00	0.18	0.18	0.73	0.00	0.00	0.37
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	5.28	0.00	0.00	0.35	0.00	0.35	0.70	0.00	0.00	0.70
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	6.14	0.88	0.00	0.44	0.44	0.00	0.88	0.00	0.00	1.75
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	11.68	0.17	0.52	0.35	0.00	0.00	1.92	0.17	0.00	2.44
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	8.55	1.86	0.00	0.00	0.00	0.00	0.74	0.00	0.00	2.60
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	17.68	2.59	0.43	0.22	0.43	0.22	4.96	0.22	0.00	4.96
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	7.37	0.41	0.00	0.41	1.23	0.00	0.82	0.00	0.41	0.82
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	5.33	0.23	0.00	0.00	0.00	0.00	1.85	0.00	0.00	0.93
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	7.89	0.93	0.00	0.93	0.00	0.00	3.25	0.00	0.00	3.25
CD14+CD16+ Monocytes, donor1	11789-124B7	34.22	4.14	0.22	0.00	0.44	0.00	32.69	0.00	0.00	42.94
CD14+CD16+ Monocytes, donor2	11801-124D1	33.73	4.16	0.69	0.92	0.92	0.46	39.73	0.00	0.00	43.20
CD14+CD16+ Monocytes, donor3	11912-125G4	32.93	1.52	0.22	0.00	0.22	0.00	25.13	0.00	0.00	33.14
CD14+CD16- Monocytes, donor1	11788-124B6	33.48	2.02	0.78	0.31	0.16	0.16	10.74	0.31	0.00	24.29
CD14+CD16- Monocytes, donor2	11799-124C8	20.26	0.70	0.70	0.17	0.17	0.00	8.38	0.17	0.00	21.66
CD14+CD16- Monocytes, donor3	11910-125G2	22.07	0.67	0.22	0.22	0.67	0.00	4.46	0.22	0.00	17.61
CD14-CD16+ Monocytes, donor1	11790-124B8	45.17	8.93	1.02	0.77	0.51	0.51	41.85	1.02	0.00	51.03
CD14-CD16+ Monocytes, donor2	11800-124C9	41.06	8.34	0.66	0.66	1.98	0.66	42.16	0.66	0.22	39.52
CD14-CD16+ Monocytes, donor3	11911-125G3	39.79	5.68	0.84	0.63	2.11	0.63	41.69	0.21	0.21	50.11
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	8.13	0.00	2.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	4.07	0.00	0.00	0.00	0.00	0.00	0.68	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	5.18	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	6.40	0.00	0.00	0.00	0.00	0.00	1.60	0.00	0.00	1.07
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	5.90	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	9.13	0.70	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	7.06	0.00	0.00	0.00	0.00	0.00	0.78	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	9.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	2.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	5.80	0.73	0.00	0.00	0.00	0.00	0.73	0.00	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	6.06	0.00	0.50	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	12.93	0.81	0.00	0.00	0.00	0.81	0.81	0.00	0.00	0.40
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	11.59	2.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.80
CD34+ Progenitors, donor1	11545-120B6	47.19	10.04	3.01	0.00	1.00	2.01	3.01	1.00	0.00	9.04
CD34+ Progenitors, donor2	11625-122B5	11.80	6.18	0.56	0.56	0.00	0.56	6.74	0.56	0.00	1.12
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	83.42	2.63	1.13	1.13	1.50	4.13	9.77	1.50	0.00	7.14
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	79.82	6.31	1.13	1.35	2.25	3.83	11.27	1.35	0.23	12.85
CD4+ T Cells, donor1	11225-116C1	5.71	0.36	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+ T Cells, donor2	11306-117C1	1.84	0.00	0.61	0.00	0.00	0.00	0.00	0.61	0.00	0.00
CD4+ T Cells, donor3	11382-118B5	5.18	0.61	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	13.02	1.28	0.00	0.00	0.26	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	22.68	0.45	0.00	0.00	0.22	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	16.67	1.44	0.29	0.29	0.29	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	4.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.47
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	7.73	0.70	0.00	0.00	0.70	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	6.59	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	16.76	2.17	1.16	0.14	0.14	0.14	0.00	0.43	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	23.22	1.69	0.17	0.34	0.34	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	21.76	1.77	0.16	0.32	0.32	0.00	0.00	0.48	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	6.28	0.45	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	9.08	0.35	0.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	3.96	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	23.19	2.95	0.00	0.42	0.00	0.00	0.00	0.42	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	33.04	3.32	0.00	0.00	0.21	0.42	0.00	0.21	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	32.41	2.34	0.67	0.00	1.00	1.00	0.00	1.00	0.33	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	7.61	0.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	4.82	0.54	0.00	0.00	0.00	0.00	0.00	1.07	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	1.79	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	26.15	2.04	0.56	0.19	0.37	0.00	0.00	0.37	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	29.24	1.73	0.43	0.87	0.22	0.22	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	30.68	3.15	0.00	0.21	0.00	0.21	0.00	0.21	0.21	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	7.58	1.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	7.37	0.43	0.00	0.43	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	6.54	1.31	0.44	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	8.41	0.49	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.49
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	3.69	0.00	0.00	0.00	0.92	0.00	0.00	0.92	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	13.96	2.79	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.40
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	8.31	0.83	0.00	0.28	0.00	0.00	0.28	0.00	0.00	1.94
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	5.40	0.49	0.25	0.00	0.00	0.25	1.47	0.00	0.00	0.98
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	6.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.54
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	13.25	1.07	0.36	0.00	0.36	0.00	0.00	0.00	0.00	1.43
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	11.08	1.38	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	4.58	0.33	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells, donor2	11307-117C2	6.01	0.75	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells, donor3	11383-118B6	4.54	0.76	0.00	0.00	0.50	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	26.38	2.98	0.23	0.23	0.46	0.23	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	29.00	2.64	0.24	0.96	0.48	0.00	0.00	0.24	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	26.54	4.65	1.09	0.00	0.27	0.27	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	22.82	4.20	0.00	0.00	0.30	0.30	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	27.36	3.36	0.72	0.48	0.72	0.24	0.00	0.48	0.48	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	28.88	2.50	1.14	0.00	0.23	0.00	0.00	0.00	0.45	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	34.98	4.35	0.43	0.43	0.22	0.22	0.00	0.43	0.43	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	33.69	3.95	0.26	0.79	0.53	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	32.60	6.10	0.23	0.70	0.94	0.00	0.00	1.17	0.23	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	38.64	5.43	0.91	0.91	0.00	0.00	0.00	0.30	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	39.51	4.65	1.16	0.87	0.29	0.00	0.00	0.58	0.29	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	48.22	7.46	2.13	0.80	0.27	0.53	0.00	0.53	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	38.52	3.50	2.63	1.31	0.44	0.88	0.00	0.44	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	37.80	0.91	1.82	0.00	1.37	0.91	0.00	0.00	0.91	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	29.83	2.24	1.49	2.24	1.49	0.00	0.00	1.49	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	28.09	3.24	1.80	0.72	0.36	0.00	0.00	0.36	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	24.74	2.59	0.00	0.86	0.29	0.00	0.00	0.58	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	24.28	2.59	0.24	0.71	0.24	0.00	0.00	0.71	0.47	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	33.27	5.70	0.95	0.32	0.00	0.00	0.00	0.00	0.32	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	33.52	3.08	0.92	0.62	0.62	0.00	0.00	0.62	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	33.34	1.92	0.32	0.96	0.32	0.32	0.00	1.28	0.32	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	38.63	4.21	2.29	0.76	0.76	0.38	0.00	0.38	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	38.62	3.94	1.18	1.18	0.39	0.00	0.00	0.79	0.39	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	37.82	2.27	0.00	0.00	0.00	0.76	0.00	0.76	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	35.33	2.41	0.00	0.00	0.80	0.00	0.00	0.80	0.80	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	32.17	2.80	0.00	0.00	0.70	0.70	0.00	0.70	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	24.04	3.01	0.00	1.00	4.01	1.00	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	34.73	14.62	0.00	3.66	0.00	0.00	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	132.42	13.34	2.47	0.99	2.47	0.49	0.00	1.48	0.00	0.49
Cardiac Myocyte, donor3	11686-122I3	159.22	8.10	2.84	1.47	1.89	1.26	0.21	1.37	0.00	0.21
Chondrocyte - de diff, donor1	11261-116G1	152.19	14.21	1.73	1.73	1.04	2.08	0.35	0.00	2.43	0.00
Chondrocyte - de diff, donor2	11338-117F6	106.97	5.69	1.07	0.71	0.71	1.42	0.36	0.71	0.71	0.00
Chondrocyte - de diff, donor3	11410-118E6	153.60	11.38	3.07	3.87	2.84	1.14	0.34	0.91	0.68	0.23
Chondrocyte - re diff, donor2	11339-117F7	250.67	30.44	4.48	2.69	5.37	7.16	0.90	2.69	9.85	2.69
Chondrocyte - re diff, donor3	11411-118E7	277.02	25.48	16.58	6.87	2.83	1.21	2.02	3.64	1.62	2.02
Ciliary Epithelial Cells, donor1	11242-116D9	163.99	14.12	1.61	2.87	3.90	5.74	1.95	1.38	1.15	0.46
Ciliary Epithelial Cells, donor2	11323-117D9	119.92	12.83	2.14	1.71	2.78	1.92	0.43	0.64	0.64	0.86
Ciliary Epithelial Cells, donor3	11399-118D4	131.24	12.21	1.68	2.48	3.01	1.59	0.35	1.06	0.88	0.35
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	60.25	3.48	2.84	2.02	2.20	1.28	0.73	1.65	2.66	0.55
Corneal Epithelial Cells, donor1	11526-119I5	76.63	2.63	1.10	1.32	0.44	0.44	0.00	0.66	0.88	0.00
Corneal Epithelial Cells, donor2	11606-120I4	53.47	6.83	0.00	0.00	1.14	0.00	0.00	1.14	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	91.52	7.16	2.56	1.53	0.26	0.77	0.00	0.00	0.51	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	49.53	4.13	0.99	0.83	0.50	0.17	1.49	0.83	0.99	2.31
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	57.40	3.47	1.89	0.63	0.63	0.00	2.21	0.00	0.00	3.15
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	37.96	10.35	0.00	0.00	0.00	0.00	3.45	3.45	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	57.88	7.45	1.19	0.76	0.97	0.43	3.35	0.65	0.22	3.56
Dendritic Cells - plasmacytoid, donor1	11228-116C4	21.87	2.39	0.34	0.00	1.37	0.34	0.34	1.02	0.00	0.34
Dendritic Cells - plasmacytoid, donor2	11309-117C4	30.68	2.61	0.65	0.00	0.00	0.00	0.65	0.65	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	17.42	1.45	0.97	0.48	0.00	0.48	0.48	1.45	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	121.74	6.00	2.84	1.67	2.00	0.50	1.50	1.17	0.33	1.17
Endothelial Cells - Aortic, donor1	11263-116G3	96.82	5.28	1.76	1.17	1.17	0.00	0.59	0.59	0.00	0.59
Endothelial Cells - Aortic, donor2	11340-117F8	111.14	7.92	2.55	0.85	1.70	0.28	2.83	0.28	0.57	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	87.68	12.58	2.36	0.39	1.18	0.00	0.00	0.39	0.79	0.79
Endothelial Cells - Artery, donor1	11264-116G4	114.31	8.14	2.33	1.75	0.58	0.58	0.00	0.29	0.00	0.00
Endothelial Cells - Artery, donor2	11341-117F9	182.81	14.59	3.76	2.59	1.41	0.47	0.00	0.71	0.47	0.71
Endothelial Cells - Artery, donor3	11413-118E9	126.92	10.52	1.93	1.58	0.70	1.58	0.00	0.70	0.70	0.35
Endothelial Cells - Lymphatic, donor1	11236-116D3	140.08	5.54	3.10	4.65	1.55	0.66	0.00	2.88	0.22	0.89
Endothelial Cells - Lymphatic, donor2	11317-117D3	177.69	6.09	5.17	2.74	2.13	1.52	0.00	1.83	0.61	0.30
Endothelial Cells - Lymphatic, donor3	11393-118C7	183.24	9.87	7.05	3.95	1.69	0.85	0.28	0.56	0.28	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	111.13	7.43	3.27	2.08	0.30	0.89	0.30	0.89	1.19	0.59
Endothelial Cells - Microvascular, donor2	11342-117G1	157.24	11.45	1.56	1.04	3.12	0.00	1.04	2.60	2.60	0.52
Endothelial Cells - Microvascular, donor3	11414-118F1	172.13	12.62	4.82	5.10	0.57	0.28	0.28	2.84	1.42	0.14
Endothelial Cells - Thoracic, donor1	11266-116G6	160.85	12.40	4.40	2.40	2.00	0.80	1.60	0.00	0.80	0.80
Endothelial Cells - Thoracic, donor2	11343-117G2	132.08	8.91	3.67	3.14	0.52	0.00	0.00	1.05	0.00	0.52
Endothelial Cells - Umbilical vein, donor1	11243-116E1	199.04	15.16	4.47	3.48	1.99	1.24	2.61	2.24	3.48	1.62
Endothelial Cells - Umbilical vein, donor2	11324-117E1	111.24	9.56	3.04	2.61	1.74	0.87	0.87	1.52	1.52	0.43
Endothelial Cells - Umbilical vein, donor3	11400-118D5	157.54	14.53	2.08	3.30	1.47	0.49	1.34	1.95	1.22	1.10
Endothelial Cells - Vein, donor1	11267-116G7	103.51	7.96	1.14	1.14	0.00	0.00	0.00	1.14	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	132.72	3.49	2.10	2.10	2.10	0.00	2.10	1.40	0.70	0.00
Endothelial Cells - Vein, donor3	11416-118F3	194.85	14.29	2.83	4.08	1.57	0.63	0.79	2.04	0.79	0.94
Eosinophils, donor1	12244-129H3	30.49	0.00	0.00	0.00	0.00	0.00	15.25	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	11.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.65
Eosinophils, donor3	12246-129H5	21.40	0.00	0.00	3.57	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	100.66	5.38	2.44	1.22	0.73	0.73	0.00	1.47	0.49	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	27.04	2.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	81.34	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	196.23	17.24	1.64	1.64	2.46	0.82	0.00	0.41	0.82	0.41
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	174.63	19.49	1.97	0.44	3.18	0.55	0.00	0.99	1.75	0.11
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	173.23	18.42	1.73	2.28	2.38	1.30	0.00	0.43	1.52	0.00
Fibroblast - Aortic Adventitial, donor1	11245-116E3	169.43	15.28	2.30	0.73	3.15	2.55	0.00	1.21	1.58	0.00
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	59.09	4.23	0.41	0.27	0.68	0.82	0.00	0.14	0.27	0.00
Fibroblast - Aortic Adventitial, donor2	11326-117E3	195.75	20.36	2.85	1.48	2.74	0.95	0.00	0.84	3.90	0.00
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	22.92	2.63	1.05	0.26	0.26	0.79	0.00	0.26	0.26	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	181.71	14.28	1.33	1.33	2.66	0.00	0.00	1.33	3.99	0.00
Fibroblast - Cardiac, donor1	11268-116G8	120.21	17.24	2.72	1.81	1.81	1.36	0.00	2.27	0.00	0.00
Fibroblast - Cardiac, donor2	11345-117G4	109.90	8.34	2.27	0.76	1.52	1.52	0.00	0.00	0.76	0.00
Fibroblast - Cardiac, donor3	11417-118F4	152.35	12.46	3.63	3.00	3.47	1.10	0.00	1.26	0.47	0.00
Fibroblast - Cardiac, donor4	11452-119A3	197.02	14.25	1.82	1.21	2.12	0.61	0.00	0.00	1.82	0.30
Fibroblast - Cardiac, donor5	11456-119A7	91.62	10.15	1.90	1.27	0.76	1.14	0.00	0.63	0.38	0.25
Fibroblast - Cardiac, donor6	11460-119B2	124.76	16.98	0.91	1.06	1.06	0.45	0.00	0.30	0.30	0.00
Fibroblast - Choroid Plexus, donor1	11492-119E7	126.89	14.87	1.47	2.14	0.27	2.28	0.13	0.54	0.40	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	88.44	15.10	0.00	0.86	2.16	2.16	0.00	0.00	0.00	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	213.86	11.72	0.00	0.00	4.39	1.46	0.00	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	147.38	4.38	2.08	1.61	0.46	0.92	0.00	1.61	0.23	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	191.14	13.40	1.02	0.85	2.04	0.85	0.00	0.68	0.51	0.00
Fibroblast - Dermal, donor1	11269-116G9	111.52	7.28	0.94	0.23	1.88	0.23	0.00	0.23	0.47	0.00
Fibroblast - Dermal, donor2	11346-117G5	79.71	6.60	0.47	0.47	0.00	1.42	0.00	0.47	0.47	0.47
Fibroblast - Dermal, donor3	11418-118F5	119.68	9.43	0.60	1.33	0.36	0.48	0.00	0.36	0.36	0.00
Fibroblast - Dermal, donor4	11450-119A1	95.30	8.25	1.70	0.45	0.79	0.34	0.00	0.45	0.34	0.00
Fibroblast - Dermal, donor5	11454-119A5	118.80	12.21	1.05	0.17	0.70	1.57	0.00	0.52	0.17	0.00
Fibroblast - Dermal, donor6	11458-119A9	123.93	12.99	2.11	0.32	1.62	1.30	0.00	1.14	0.16	0.00
Fibroblast - Gingival, donor1	11237-116D4	139.72	10.83	1.04	0.83	2.71	0.62	0.00	0.42	0.83	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	264.88	31.70	1.83	1.83	5.76	1.83	0.00	1.57	5.50	0.00
Fibroblast - Gingival, donor2	11318-117D4	197.54	19.37	1.32	1.84	2.50	1.58	0.53	0.79	0.26	0.13
Fibroblast - Gingival, donor3	11394-118C8	174.62	10.93	1.74	2.03	0.97	0.77	0.10	0.39	1.06	0.10
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	189.08	10.39	2.08	0.00	1.04	2.08	0.00	0.00	1.04	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	155.59	14.80	0.88	1.59	1.94	0.18	0.00	0.70	3.00	0.00
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	196.27	21.51	2.18	0.94	3.12	1.87	0.31	1.71	0.62	0.00
Fibroblast - Gingival, donor6 (control)	11922-125H5	177.55	22.99	1.35	1.22	3.11	1.76	0.54	0.54	0.41	0.00
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	411.46	41.29	2.82	5.29	6.70	0.71	0.00	2.47	2.82	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	238.38	26.62	1.17	0.88	3.80	1.90	0.00	0.88	0.73	0.00
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	203.30	24.82	1.64	0.82	3.82	2.05	0.41	0.82	0.55	0.14
Fibroblast - Gingival, donor8 (control)	11926-125H9	194.49	25.56	1.10	1.54	2.52	1.54	0.00	0.33	0.66	0.11
Fibroblast - Gingival, donor9 (control)	11927-125I1	205.29	21.28	1.32	1.61	1.91	1.17	0.00	0.59	4.84	0.00
Fibroblast - Lung, donor1	11270-116H1	55.73	5.44	0.00	0.00	0.00	0.00	0.00	1.36	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	96.99	10.45	5.97	0.00	0.00	1.49	0.00	1.49	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	186.77	16.88	1.27	2.74	1.69	0.42	0.00	0.84	0.00	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	173.27	20.83	3.33	2.50	0.00	3.33	0.00	0.83	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	130.07	11.19	0.00	0.00	0.00	1.40	0.00	1.40	1.40	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	112.23	12.87	2.24	0.84	0.84	0.56	0.00	1.12	0.28	0.00
Fibroblast - Mammary, donor1	11540-120B1	307.32	19.49	1.22	1.22	3.25	0.41	0.00	0.00	1.62	0.00
Fibroblast - Mammary, donor2	11620-122A9	107.84	15.98	3.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	256.12	17.87	0.00	0.00	0.00	5.96	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	195.33	8.92	2.33	0.78	1.55	0.97	0.19	0.97	0.39	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	205.07	20.33	2.28	1.21	2.43	2.12	0.30	1.21	0.76	0.00
Fibroblast - Periodontal Ligament, donor3	11395-118C9	231.02	12.85	0.92	0.31	1.22	0.31	0.31	0.61	0.61	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	141.96	14.88	2.67	1.14	1.91	0.38	0.00	0.38	0.38	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	188.18	27.54	2.97	1.89	2.97	0.81	0.00	0.27	0.81	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	130.24	11.13	1.74	2.32	1.39	0.12	0.00	0.12	3.13	0.00
Fibroblast - Pulmonary Artery, donor1	11250-116E8	188.13	16.58	2.21	0.99	2.87	0.88	0.11	0.88	0.33	0.00
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	283.65	24.38	3.25	2.64	4.27	1.02	0.00	0.61	0.20	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	100.23	8.02	0.00	0.67	0.00	0.00	0.00	0.67	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	118.61	7.12	1.19	0.40	0.79	1.19	0.00	0.79	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	34.73	5.16	0.79	0.40	0.20	1.19	0.20	0.79	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	153.82	9.41	1.95	2.49	1.07	1.42	0.18	0.71	0.18	0.18
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	159.05	8.08	2.96	0.79	1.97	0.59	0.20	1.18	0.79	0.00
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	42.12	6.32	0.90	0.60	0.60	0.30	0.30	0.30	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	133.00	17.49	1.73	1.30	1.08	2.37	0.22	0.97	1.51	0.00
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	27.33	2.28	1.52	0.51	0.00	0.76	0.25	0.25	0.00	0.00
Fibroblast - skin normal, donor1	11553-120C5	176.22	16.74	2.30	2.79	2.79	0.66	0.16	1.31	0.66	0.49
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	81.81	5.41	1.00	0.40	1.80	0.60	0.00	0.20	0.00	0.00
Fibroblast - skin normal, donor2	11561-120D4	195.70	32.85	2.41	1.81	2.31	1.61	0.20	0.80	1.21	0.00
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	29.62	2.72	0.00	0.00	0.00	0.91	0.00	0.60	0.00	0.30
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	167.10	10.52	2.49	1.66	1.57	0.75	0.17	0.99	1.08	0.00
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	118.98	10.60	1.37	1.20	0.51	0.68	0.00	0.34	1.37	0.17
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	37.44	3.28	0.66	0.33	0.99	0.33	0.00	1.31	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	148.49	25.14	2.34	1.28	1.81	2.77	0.32	1.07	1.49	0.21
Fibroblast - skin walker warburg, donor1	11554-120C6	211.69	20.07	3.54	3.37	3.37	1.35	0.17	1.35	0.00	0.17
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	145.53	18.66	2.20	1.10	1.73	3.14	0.31	0.31	0.47	0.16
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	332.40	44.32	0.00	0.00	22.16	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	55.78	18.30	1.74	1.74	2.61	0.00	0.00	0.00	3.49	1.74
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	136.26	11.09	1.73	0.87	1.21	0.52	0.00	1.73	0.17	0.00
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	175.92	8.07	2.60	1.30	1.56	0.78	0.00	1.56	0.00	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	133.12	12.52	1.53	0.77	1.79	1.28	0.00	0.77	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	189.86	19.90	7.66	1.53	8.42	2.30	0.00	0.00	2.30	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	166.54	21.69	6.38	5.10	14.68	1.28	0.64	4.47	5.10	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	122.09	11.41	7.13	3.99	3.14	1.43	0.00	3.14	0.86	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	146.43	2.21	6.07	5.24	1.10	0.28	0.00	0.83	13.51	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	87.68	5.48	3.65	2.97	2.28	2.28	0.00	0.91	4.11	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	156.92	10.70	3.17	7.53	4.56	0.99	0.00	3.57	2.97	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	163.62	4.23	4.49	5.55	0.79	0.26	0.00	1.85	11.37	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	120.35	6.20	3.91	3.91	1.63	2.28	0.00	0.98	4.57	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	115.42	10.17	1.33	3.10	3.10	1.33	0.00	3.10	1.77	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	90.02	8.20	2.83	2.26	3.96	0.85	0.00	3.39	1.13	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	64.90	6.77	2.59	2.22	1.85	0.99	0.12	0.99	0.62	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	100.73	9.40	3.49	2.95	4.30	1.88	0.00	1.61	0.81	0.27
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	91.31	4.96	5.33	4.58	1.73	1.73	0.00	5.08	0.37	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	91.36	6.37	5.95	3.88	1.66	1.52	0.00	5.12	0.14	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	80.51	7.93	4.07	2.85	0.81	0.61	0.00	2.85	1.22	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	91.73	4.56	3.19	1.14	2.28	1.83	0.00	3.42	1.14	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	79.85	7.22	4.48	3.24	1.99	1.49	0.00	3.74	0.62	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	89.83	5.68	3.50	3.93	1.31	0.66	0.00	2.62	0.87	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	88.35	5.61	4.14	1.48	0.59	4.43	0.00	0.89	0.89	0.30
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	96.96	6.20	4.29	2.07	1.59	2.86	0.00	2.54	1.27	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	85.57	2.90	4.02	3.13	1.34	0.89	0.00	1.79	0.67	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	108.88	5.44	4.44	2.22	1.41	4.84	0.00	2.02	0.60	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	92.12	8.48	5.09	3.56	1.53	5.09	0.00	3.39	0.34	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	138.51	8.07	6.65	3.46	2.39	3.19	0.00	3.46	0.53	0.09
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	158.48	7.08	7.08	2.39	1.98	6.45	0.10	3.85	2.19	0.21
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	127.23	6.83	4.61	3.07	1.02	6.83	0.17	2.39	1.02	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	91.95	5.75	2.77	1.88	1.44	2.32	0.00	2.21	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	129.37	7.65	6.07	3.16	3.58	4.16	0.00	2.50	0.58	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	101.27	6.53	4.70	1.02	2.45	3.68	0.00	1.43	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	101.50	3.92	2.89	3.30	1.03	2.89	0.00	2.48	0.41	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	97.08	5.30	4.27	2.19	2.19	3.00	0.00	2.65	1.15	0.12
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	101.56	6.34	3.67	1.50	2.33	3.17	0.00	2.17	0.17	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	86.63	3.97	3.31	1.98	1.54	2.42	0.00	2.65	0.44	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	84.99	5.41	2.83	1.35	0.98	3.07	0.12	1.84	0.74	0.12
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	106.66	8.92	4.86	2.76	3.24	4.05	0.16	1.62	0.81	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	74.09	4.49	1.60	1.92	0.96	1.60	0.32	2.25	0.96	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	85.47	5.97	3.70	2.08	1.61	2.65	0.09	1.99	0.76	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	76.08	4.43	3.64	1.58	1.11	3.48	0.00	1.74	0.32	0.16
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	86.66	6.69	3.95	0.91	1.82	4.26	0.00	1.82	0.30	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	94.50	7.11	4.29	3.03	1.57	3.14	0.00	2.72	0.63	0.10
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	68.06	4.17	2.42	1.10	1.32	1.10	0.00	0.66	0.44	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	99.59	4.77	3.09	1.68	1.96	3.93	0.28	2.24	1.12	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	112.59	9.91	3.80	1.94	3.15	4.17	0.00	1.94	0.93	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	100.81	9.36	5.08	0.80	1.07	2.94	0.00	1.87	1.07	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	138.62	10.71	4.44	2.45	2.91	2.91	0.00	2.30	0.31	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	137.31	12.18	4.27	2.59	2.85	2.72	0.13	2.72	1.17	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	85.12	7.59	0.81	1.08	1.36	1.90	0.00	1.90	0.27	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	146.37	12.17	3.87	2.95	1.29	5.53	0.37	2.21	0.37	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	151.76	13.16	5.26	2.63	1.75	5.48	0.00	3.07	0.44	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	118.02	6.94	3.97	2.98	1.98	2.98	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	180.06	12.53	7.26	3.56	3.56	4.22	0.00	2.37	0.40	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	175.33	14.53	3.43	2.62	2.62	4.04	0.00	2.02	0.20	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	175.12	8.13	2.29	2.80	1.78	6.10	0.00	2.03	1.52	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	70.67	8.16	3.78	3.18	1.59	2.19	0.00	2.79	0.60	0.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	62.71	5.24	2.77	1.54	2.62	0.31	0.00	1.39	0.46	0.00
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	102.70	9.62	4.50	5.93	2.86	1.84	0.00	3.07	1.02	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	187.76	17.84	4.69	6.26	7.51	2.19	0.00	2.82	0.63	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	170.38	16.67	5.37	4.80	7.06	2.54	0.00	2.83	1.70	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	111.15	7.84	3.23	5.07	1.84	0.46	0.00	1.38	5.53	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	153.44	17.32	4.95	0.00	7.42	2.47	0.00	2.47	2.47	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	124.17	9.67	3.87	3.09	7.35	3.48	0.00	0.39	1.16	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	129.96	9.63	0.00	1.60	3.21	0.00	0.00	4.81	3.21	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	104.33	15.65	5.22	3.48	0.00	1.74	0.00	1.74	10.43	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	107.08	6.84	3.58	3.25	2.28	1.63	0.00	2.28	4.23	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	86.48	8.65	3.29	2.06	3.29	0.41	0.00	3.29	1.65	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	156.62	13.33	0.00	6.66	0.00	0.00	0.00	0.00	3.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	91.44	5.59	2.80	2.24	1.96	1.12	0.00	1.68	1.68	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	100.34	5.88	3.27	3.92	3.27	1.63	0.00	2.29	0.98	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	98.98	6.71	10.07	8.39	2.52	0.84	0.00	0.84	1.68	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	92.24	5.09	6.36	1.27	1.91	0.64	0.00	1.91	4.13	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	93.41	5.77	4.76	1.36	1.70	1.36	0.00	2.38	2.04	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	85.61	6.26	4.18	2.09	2.09	6.26	0.00	4.18	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	96.79	8.02	3.44	1.15	4.01	1.72	0.00	2.86	1.15	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	83.17	5.33	1.78	2.07	0.89	0.59	0.00	0.89	1.18	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	77.93	8.47	0.00	1.69	3.39	0.00	0.00	3.39	3.39	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	86.98	11.60	1.24	2.49	3.31	3.31	0.00	2.07	1.24	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	95.96	6.90	3.22	1.84	2.53	2.99	0.00	2.76	1.38	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	121.18	15.81	5.27	0.00	0.00	0.00	0.00	5.27	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	72.27	4.23	2.31	0.77	0.00	0.38	0.00	0.00	0.38	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	68.45	3.26	1.30	0.33	1.63	1.63	0.00	1.63	1.63	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	101.66	4.68	2.68	2.01	0.67	0.00	0.00	0.67	2.68	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	58.18	1.16	0.77	0.39	0.77	0.39	0.00	2.31	1.16	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	86.27	7.53	3.42	2.05	2.05	1.03	0.00	2.05	0.68	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	111.82	2.48	0.00	0.00	0.00	0.00	0.00	4.97	2.48	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	73.61	1.42	2.83	1.89	0.00	0.94	0.00	0.47	3.77	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	74.23	4.22	0.60	1.21	1.81	0.00	0.00	0.60	1.21	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	75.79	2.03	3.05	2.54	0.51	1.02	0.00	3.56	2.54	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	84.55	3.19	0.80	0.40	1.60	0.80	0.00	1.99	1.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	65.12	0.49	2.47	0.99	0.49	0.99	0.00	2.96	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	76.73	1.18	3.54	0.00	1.18	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	87.52	1.75	1.17	0.00	0.58	1.17	0.00	1.75	1.75	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	68.03	2.19	1.32	2.19	0.44	0.44	0.00	0.88	0.44	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	65.27	4.24	2.54	0.85	0.00	0.00	0.00	0.85	0.85	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	52.53	6.57	1.19	1.19	2.39	0.60	0.00	1.79	0.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	49.50	2.43	0.97	0.97	1.94	3.40	0.00	0.97	1.46	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	79.89	4.57	0.00	1.14	1.14	1.14	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	155.52	12.47	1.66	0.42	1.66	0.83	0.00	1.66	0.42	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	107.95	10.12	1.12	0.00	3.37	1.12	0.00	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	57.41	4.76	0.00	0.32	0.95	1.27	0.00	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	66.42	6.27	0.42	0.00	1.25	0.00	0.00	0.42	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	89.24	11.37	4.29	2.20	1.28	1.74	0.00	2.90	0.00	0.00
Hep-2 cells mock treated, biol_rep2	11899-125E9	89.63	11.98	4.73	2.19	1.69	0.84	0.00	2.36	0.17	0.00
Hep-2 cells mock treated, biol_rep3	11900-125F1	91.68	9.33	2.28	2.05	1.14	1.82	0.00	1.14	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	86.35	10.71	4.92	1.86	1.64	1.75	0.00	3.61	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	82.53	13.32	3.65	0.86	0.86	1.50	0.00	1.29	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	78.58	8.40	3.88	1.72	0.65	2.37	0.00	2.37	0.22	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	93.53	7.60	3.86	2.24	1.87	2.37	0.00	2.37	0.50	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	69.99	8.06	2.74	0.69	1.03	0.69	0.00	1.37	0.17	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	76.57	8.97	4.49	1.60	0.96	0.32	0.00	2.24	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	204.82	19.59	4.48	8.39	1.12	2.80	0.56	2.80	1.12	0.56
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	161.43	12.12	2.60	3.46	2.60	0.87	0.43	2.16	0.87	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	84.60	21.15	0.00	0.00	5.29	2.64	0.00	5.29	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	173.19	6.70	2.82	2.12	2.12	1.06	0.00	0.35	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	156.20	17.44	1.45	1.45	2.18	0.73	0.00	0.73	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	116.44	12.41	1.40	1.05	2.97	1.75	0.00	0.52	0.00	0.00
Hepatocyte, donor1	11523-119I2	12.11	0.00	1.21	0.00	0.00	1.21	0.00	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	56.02	6.46	3.23	2.15	1.08	1.08	1.08	1.08	0.00	0.00
Hepatocyte, donor3	11684-122I1	25.77	3.07	1.84	0.00	0.00	0.61	0.61	0.00	0.00	1.23
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	23.50	4.57	2.61	0.00	1.96	1.31	0.00	0.00	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	41.25	3.32	1.75	0.70	0.52	0.52	0.00	1.05	0.70	0.00
Iris Pigment Epithelial Cells, donor1	11530-119I9	127.88	7.27	2.33	1.37	2.20	2.74	0.41	1.65	0.14	0.55
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	3.18	0.00	3.18	0.00	0.00	0.00	0.00	3.18	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	13.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	16.61	1.38	1.38	1.38	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	5.01	0.00	0.00	0.00	0.00	0.00	0.00	2.50	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	23.74	11.87	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	10.25	2.56	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	13.71	0.00	4.57	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	16.24	3.25	0.00	0.00	0.00	0.00	0.00	1.62	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	13.34	0.00	0.00	0.00	0.00	0.00	0.00	1.67	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	7.26	0.00	3.63	0.00	0.00	3.63	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	19.85	1.32	3.97	1.32	0.00	0.00	0.00	1.32	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	22.17	1.11	0.00	1.11	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	10.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	14.49	1.89	0.00	1.26	0.63	0.00	0.00	1.26	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	17.01	0.00	0.00	0.00	0.00	0.00	0.00	1.55	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	23.90	2.58	1.29	0.65	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	17.71	0.00	0.00	0.00	1.61	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	35.84	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	18.74	1.63	0.81	0.00	0.00	0.00	0.00	0.81	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	13.01	0.00	0.42	0.42	0.42	0.00	0.00	0.84	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	14.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	16.07	1.61	0.80	0.80	0.00	0.00	0.00	2.41	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	11.08	0.00	0.92	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	22.66	1.42	2.83	0.94	0.00	0.00	0.00	0.47	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	13.60	0.91	0.91	0.00	0.00	0.00	0.00	1.81	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	29.06	1.08	3.23	0.00	0.00	0.00	0.00	1.08	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	20.33	1.27	0.00	2.54	0.00	0.00	0.00	1.27	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	12.12	0.64	3.83	0.00	0.00	0.64	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	18.23	1.82	0.00	3.65	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	31.61	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	13.57	1.43	1.43	1.43	0.00	0.00	0.00	0.71	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	6.64	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	23.77	2.16	1.85	0.93	0.00	0.31	0.00	0.62	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	8.78	7.02	0.00	1.76	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	12.57	3.14	0.00	0.00	0.00	0.00	0.00	3.14	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	21.56	0.70	0.70	0.00	0.70	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	13.28	2.21	0.00	2.21	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	16.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	13.08	1.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	13.50	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	17.42	0.00	0.00	0.00	0.00	0.00	0.00	3.48	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	13.87	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	13.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	19.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	16.57	2.76	0.92	0.92	0.00	0.00	0.00	0.92	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	9.08	3.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	8.46	0.00	2.11	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	107.79	10.85	1.88	0.82	1.63	0.16	0.00	1.22	0.49	0.00
Keratinocyte - epidermal, donor2	11349-117G8	50.36	4.69	1.17	0.59	0.59	0.00	0.00	0.59	0.59	0.00
Keratinocyte - epidermal, donor3	11421-118F8	121.44	8.33	2.27	1.61	1.04	0.38	0.00	1.70	0.28	0.00
Keratinocyte - oral, donor1	11251-116E9	89.79	4.77	1.82	0.68	1.25	0.34	0.00	0.79	0.45	0.00
Keratocytes, donor1	11527-119I6	154.72	6.88	2.06	0.69	1.03	1.38	0.34	0.69	0.34	0.00
Keratocytes, donor2	11607-120I5	146.48	12.89	1.17	1.17	2.34	0.00	1.17	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	86.15	5.53	0.59	1.19	0.40	0.99	0.00	0.00	0.00	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	21.98	0.00	2.20	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	134.84	10.79	2.16	0.00	3.24	1.08	1.08	2.16	0.00	1.08
Lens Epithelial Cells, donor2	11609-120I7	165.73	6.46	3.58	3.81	3.11	3.23	3.58	2.08	0.12	0.23
Lens Epithelial Cells, donor3	11690-122I7	107.77	7.57	1.31	1.31	1.61	1.92	0.50	1.01	0.10	0.30
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	151.66	10.55	4.15	3.20	2.02	1.07	1.54	2.37	0.59	1.30
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	98.79	8.93	2.79	1.12	1.40	1.12	1.40	0.56	0.28	0.84
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	147.34	10.55	3.31	3.62	1.26	2.05	2.68	3.46	0.63	1.57
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	82.81	11.29	2.15	1.08	1.08	1.61	1.08	2.69	0.00	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	109.05	9.77	3.15	1.89	0.95	1.26	0.95	1.58	0.00	1.58
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	115.15	11.32	3.34	3.34	1.83	0.54	2.16	2.48	0.32	0.86
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	97.26	8.62	2.05	2.46	1.23	0.82	1.23	1.23	0.41	1.23
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	86.72	6.57	2.02	0.51	1.01	1.26	1.26	1.52	0.25	0.51
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	111.47	11.26	3.10	1.97	1.13	1.13	1.97	2.67	0.14	1.13
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	82.27	9.10	1.58	1.19	1.58	1.19	0.79	0.79	0.40	0.79
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	114.97	12.60	4.65	2.71	1.16	0.39	1.94	2.33	0.78	0.58
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	78.50	5.92	2.41	1.67	0.93	1.11	0.93	1.11	0.19	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	99.65	9.06	5.23	0.70	1.74	0.35	0.35	1.39	0.70	1.05
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	126.89	7.87	3.34	3.10	1.19	0.72	2.62	2.15	0.95	0.95
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	116.61	11.67	4.26	2.47	1.37	1.51	1.37	1.65	1.24	1.79
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	102.55	10.47	2.46	1.85	2.46	0.00	1.54	2.16	0.31	0.92
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	78.25	9.35	1.87	2.18	0.31	0.94	0.94	0.62	0.62	0.94
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	115.47	9.15	4.39	1.65	1.65	0.73	2.38	1.28	0.37	1.10
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	104.00	9.87	2.30	1.65	2.30	0.99	2.30	2.96	0.00	1.65
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	75.85	5.27	2.64	2.05	0.88	0.59	0.00	0.59	0.00	0.59
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	78.91	6.97	2.49	1.74	0.75	0.25	1.24	1.24	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	114.94	9.21	2.91	1.45	0.97	0.48	2.91	3.39	0.00	1.45
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	101.52	7.27	2.96	1.89	1.62	0.81	1.35	3.77	0.27	0.81
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	108.99	13.17	4.39	3.63	1.51	0.61	1.51	1.97	0.30	1.36
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	72.06	9.33	3.11	0.52	1.04	1.04	2.07	2.59	0.00	0.52
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	115.37	9.00	3.98	2.72	1.26	0.63	1.88	2.30	0.42	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	110.22	11.13	3.61	3.01	2.41	0.30	1.05	3.01	0.30	0.60
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	90.11	6.19	2.75	2.75	0.69	0.69	0.00	2.06	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	107.81	10.16	3.57	2.63	1.51	1.13	1.88	1.88	0.38	1.13
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	100.30	11.03	4.14	1.80	1.91	0.64	1.17	2.33	0.53	0.95
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	102.25	8.24	3.88	1.94	0.00	0.48	0.48	0.48	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	91.63	7.28	1.32	2.32	0.99	0.33	0.33	2.98	0.33	0.66
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	111.75	10.16	5.45	2.35	0.99	0.87	0.99	3.35	0.37	0.12
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	104.03	7.03	2.59	3.33	1.85	1.85	1.11	4.07	0.00	1.48
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	117.12	8.65	3.21	1.48	0.99	0.49	1.73	1.73	0.00	0.74
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	109.44	9.21	2.47	1.92	1.65	0.69	2.20	2.34	0.27	0.55
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	114.50	7.72	2.25	1.93	0.96	0.64	0.32	2.57	0.32	1.93
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	115.04	8.83	2.43	1.52	0.61	1.52	2.13	2.13	0.00	0.61
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	142.49	14.00	4.76	3.08	1.54	1.12	1.26	2.94	0.56	2.24
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	114.14	11.38	4.62	1.07	0.71	0.36	1.42	0.36	1.07	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	79.99	10.18	3.88	1.94	0.48	2.42	0.97	0.97	0.97	0.48
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	90.41	6.69	2.96	2.02	0.78	0.62	0.78	1.87	0.00	0.93
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	113.52	9.31	3.58	1.43	1.43	0.72	1.79	1.43	0.00	1.43
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	94.41	8.17	4.25	2.29	0.00	0.65	1.96	2.29	0.33	0.65
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	81.46	6.59	3.06	1.18	1.41	0.47	1.65	2.59	0.47	1.18
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	151.10	10.89	5.57	2.48	1.24	0.99	1.98	2.23	0.50	0.87
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	88.36	7.43	3.07	2.31	1.02	0.26	1.02	1.79	0.26	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	95.47	6.56	3.28	0.60	0.60	0.00	0.30	1.79	0.00	1.49
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	40.79	0.00	2.27	2.27	4.53	9.06	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	36.06	6.14	1.53	1.53	4.60	0.00	0.00	2.30	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	47.50	1.48	1.48	1.48	1.48	0.74	0.00	1.48	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	34.70	8.46	2.12	0.85	0.85	0.85	0.00	0.00	0.42	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	37.98	2.81	4.22	0.70	0.70	1.41	0.00	4.22	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	42.03	4.67	0.93	0.00	0.93	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	27.82	5.67	2.06	0.52	2.58	0.52	0.00	1.03	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	24.98	3.57	0.00	2.38	4.76	0.00	0.00	3.57	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	45.92	6.56	2.71	1.58	1.36	0.45	0.00	1.58	0.45	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	35.77	9.02	2.33	0.87	2.91	1.74	0.00	1.45	0.29	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	45.02	9.90	0.90	1.35	1.35	0.00	0.00	0.45	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	54.33	10.03	4.88	0.81	3.25	1.08	0.00	2.03	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	34.92	8.22	3.08	0.51	1.54	1.03	0.00	1.54	0.51	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	43.40	7.41	2.47	2.12	3.18	1.06	0.00	0.71	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	38.65	6.00	2.00	0.00	2.67	0.67	0.00	0.67	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	48.90	8.15	2.04	0.51	1.53	0.00	0.00	4.58	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	48.29	5.87	2.40	1.33	1.87	0.80	0.00	1.33	0.27	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	43.84	7.18	2.65	1.89	1.51	0.38	0.00	0.76	0.38	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	44.18	6.14	2.45	2.45	3.07	0.61	0.00	1.84	0.61	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	52.19	6.52	2.45	1.63	4.08	0.82	0.00	1.63	0.82	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	49.15	7.50	3.96	1.25	2.92	0.62	0.00	1.25	0.83	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	48.20	9.25	1.96	1.96	1.68	0.84	0.00	2.52	0.84	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	46.37	3.09	2.06	1.03	4.12	0.00	0.00	1.03	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	43.84	8.42	3.48	2.32	0.87	0.58	0.00	2.03	0.87	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	48.13	10.76	2.39	1.79	2.09	0.60	0.00	1.49	0.30	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	58.09	6.09	1.11	0.55	2.21	0.00	0.00	2.77	1.11	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	48.07	6.72	3.89	1.41	2.47	0.00	0.00	1.41	0.35	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	56.05	9.96	2.95	0.37	3.32	0.37	0.00	1.11	1.11	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	33.39	8.06	2.30	2.30	1.15	0.00	0.00	3.45	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	45.67	9.59	0.77	2.30	3.07	0.00	0.00	1.92	0.38	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	46.99	5.66	3.40	1.13	1.70	0.57	0.00	2.26	0.57	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	41.84	8.20	1.64	1.64	0.82	0.00	0.00	0.82	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	50.61	9.49	3.16	1.36	2.71	0.90	0.00	1.81	0.45	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	38.78	15.80	1.44	2.87	3.59	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	56.76	8.22	1.49	0.00	2.99	0.75	0.00	1.49	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	50.91	14.12	4.46	0.74	1.11	0.74	0.00	1.49	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	47.38	6.46	3.88	2.15	1.72	0.43	0.00	1.29	0.43	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	42.81	6.85	3.43	0.86	1.71	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	47.98	6.33	2.67	1.67	1.00	0.67	0.00	1.33	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	36.80	4.83	4.22	0.00	2.41	1.21	0.00	1.81	1.21	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	43.37	6.40	2.13	2.13	1.42	0.71	0.00	2.13	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	50.53	5.84	3.44	1.03	0.69	0.00	0.00	2.41	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	38.65	10.73	1.07	1.07	2.15	0.00	0.00	2.15	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	59.93	9.43	1.35	0.00	2.69	0.00	0.00	2.02	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	55.93	11.48	3.70	1.48	2.59	0.37	0.00	1.11	0.37	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	50.01	8.14	1.16	1.16	0.00	1.16	0.00	3.49	2.33	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	51.83	8.46	5.29	1.06	0.00	0.00	0.00	2.12	1.06	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	44.02	4.80	2.00	0.80	1.20	0.40	0.00	2.40	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	35.62	9.45	3.63	0.73	2.18	0.00	0.00	0.73	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	54.42	9.96	1.53	0.77	1.53	1.53	0.00	0.77	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	29.60	4.44	0.99	0.99	3.45	0.49	0.00	0.00	0.49	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	40.46	9.41	3.76	0.00	0.94	0.00	0.00	0.94	0.94	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	55.81	11.56	3.02	1.51	3.52	1.01	0.00	2.51	0.50	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	48.22	3.15	2.25	2.25	2.70	0.00	0.00	1.80	0.45	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	30.98	3.44	3.44	0.00	3.44	0.00	0.00	1.72	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	46.32	4.90	1.78	1.78	3.56	0.89	0.00	2.67	0.45	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	44.97	5.08	1.96	1.17	2.35	0.78	0.00	1.96	1.96	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	28.37	5.28	1.32	0.00	1.32	1.98	0.00	0.66	0.66	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	57.60	6.23	3.63	0.52	0.52	1.04	0.00	2.59	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	42.44	7.88	2.19	1.31	1.75	1.31	0.00	0.44	0.44	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	38.58	8.95	1.68	0.00	1.68	0.00	0.00	0.56	0.56	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	48.58	8.39	2.21	1.32	3.09	0.44	0.00	1.32	0.44	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	50.53	5.79	2.70	0.39	1.93	0.00	0.00	1.16	0.77	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	36.96	6.08	4.56	0.51	2.53	1.52	0.00	2.03	0.51	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	47.10	7.21	3.36	1.44	2.40	0.00	0.00	1.44	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	52.48	7.95	2.39	0.80	1.19	1.59	0.00	2.78	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	44.96	8.51	0.61	0.61	1.82	0.61	0.00	2.43	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	24.90	4.84	1.38	1.38	0.69	1.38	0.00	0.69	1.38	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	48.64	7.22	3.04	1.14	3.04	0.38	0.38	1.90	1.14	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	38.21	7.23	1.55	1.03	1.03	1.03	0.00	0.52	2.07	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	38.09	10.88	4.23	0.60	0.00	0.00	0.00	1.21	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	42.15	9.82	2.54	1.27	2.54	0.95	0.00	1.90	0.63	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	52.24	4.80	1.07	1.07	1.07	1.07	0.00	1.07	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	25.29	3.45	2.87	1.15	0.00	1.15	0.00	1.72	1.72	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	50.91	8.74	1.54	1.03	2.06	0.51	0.00	2.57	1.54	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	40.32	7.78	2.83	0.71	2.12	0.71	0.00	1.41	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	32.91	7.38	1.13	0.57	0.57	1.70	0.00	2.84	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	46.18	9.98	2.50	0.83	2.91	0.00	0.00	2.08	1.25	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	42.28	7.05	2.35	1.57	1.57	0.78	0.00	0.00	0.78	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	30.48	8.77	2.09	2.09	0.42	0.42	0.00	2.92	0.84	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	50.65	9.29	3.25	1.39	1.86	0.46	0.00	3.25	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	42.82	2.68	2.01	0.67	0.67	1.34	0.00	1.34	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	36.89	8.02	2.14	0.53	0.53	1.60	0.00	3.21	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	49.70	11.72	4.85	1.62	2.83	0.40	0.00	2.83	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	43.13	6.42	1.84	0.00	0.92	0.00	0.00	0.92	0.92	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	28.45	7.11	1.78	0.89	1.78	0.00	0.00	2.67	0.89	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	47.87	11.40	1.14	1.14	2.28	0.00	0.00	2.85	0.57	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	48.31	9.97	3.83	0.77	0.77	1.53	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	33.38	6.57	1.64	1.09	1.09	0.55	0.00	2.74	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	56.57	8.46	2.67	4.01	1.78	0.00	0.00	2.23	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	78.51	9.36	3.38	2.34	2.60	0.78	0.00	2.60	0.52	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	33.82	3.98	2.65	0.66	1.99	1.33	0.00	3.32	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	66.52	10.39	4.16	0.00	2.08	0.00	0.00	2.08	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	21.20	1.14	0.23	0.23	0.46	0.23	0.91	0.00	0.00	1.60
Macrophage - monocyte derived, donor2	11313-117C8	26.79	3.12	0.18	1.10	0.73	0.18	1.65	0.37	0.18	1.84
Macrophage - monocyte derived, donor3	11389-118C3	39.19	5.51	0.66	1.31	0.13	0.26	1.84	0.26	0.13	1.97
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	143.91	14.87	2.66	1.06	1.06	0.53	0.00	1.59	0.53	0.00
Mallassez-derived cells, donor2	11929-125I3	115.04	14.89	1.90	1.27	1.90	0.48	0.00	0.95	0.63	0.00
Mallassez-derived cells, donor3	11930-125I4	106.74	12.65	0.97	0.97	1.39	0.28	0.00	0.28	0.56	0.00
Mammary Epithelial Cell, donor1	11273-116H4	113.49	8.17	2.29	0.80	0.70	1.00	0.00	1.40	0.40	0.00
Mammary Epithelial Cell, donor2	11350-117G9	116.98	12.45	3.19	1.16	2.32	0.58	0.00	0.87	0.00	0.00
Mammary Epithelial Cell, donor3	11422-118F9	112.49	9.73	2.99	1.00	1.25	0.25	0.00	1.00	0.50	0.00
Mast cell - stimulated, donor1	11487-119E2	66.44	17.63	0.00	0.00	2.03	0.68	4.75	0.00	2.03	5.42
Mast cell, donor1	11563-120D6	42.61	1.84	1.19	0.76	0.43	0.22	2.16	1.62	0.87	1.30
Mast cell, donor2	11565-120D8	19.02	0.89	0.00	0.00	0.00	0.00	2.67	0.00	1.19	0.59
Mast cell, donor3	11566-120D9	22.29	0.23	0.00	0.68	0.23	0.00	6.30	0.45	0.68	4.73
Mast cell, donor4	11567-120E1	17.73	0.53	0.53	0.35	0.18	0.00	1.24	0.18	0.89	2.66
Mast cell, expanded and stimulated, donor5	11940-126A5	24.73	2.00	0.44	0.11	0.11	0.33	1.00	0.33	0.55	1.00
Mast cell, expanded and stimulated, donor8	11942-126A7	57.78	14.59	0.58	1.75	0.00	0.58	0.58	0.00	1.75	0.58
Mast cell, expanded, donor5	11939-126A4	29.14	1.26	0.46	0.46	0.00	0.11	0.80	0.23	1.38	2.06
Mast cell, expanded, donor8	11941-126A6	42.68	1.84	1.51	0.50	0.67	0.00	0.67	0.33	0.84	1.67
Melanocyte - dark, donor1	11502-119F8	318.29	14.63	11.04	8.56	3.38	1.79	1.79	4.08	0.00	0.50
Melanocyte - dark, donor2	11582-120F7	131.86	18.69	1.73	0.69	1.38	2.08	0.00	0.35	0.00	0.00
Melanocyte - dark, donor3	11663-122F7	184.29	9.06	1.09	0.94	2.90	4.93	3.48	0.43	0.51	0.80
Melanocyte - light, donor1	11274-116H5	131.41	6.11	0.24	1.18	1.18	1.41	0.00	0.00	4.00	0.24
Melanocyte - light, donor2	11351-117H1	53.91	3.41	0.00	0.00	0.00	2.73	0.00	0.00	0.00	0.00
Melanocyte - light, donor3	11423-118G1	82.39	6.07	1.73	0.00	0.00	0.87	0.87	0.00	2.60	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	199.40	11.87	2.92	1.98	1.98	2.29	1.25	1.25	1.04	0.42
Melanocyte, donor2 (MC+2)	12739-135I3	177.77	16.41	1.08	1.08	2.15	2.96	0.27	1.08	0.81	0.54
Melanocyte, donor3 (MC+3)	12837-137B2	131.78	6.70	1.61	0.54	0.80	1.34	0.00	1.07	0.80	0.00
Meningeal Cells, donor1	11493-119E8	172.82	14.27	2.23	2.48	0.87	2.85	0.00	1.61	0.12	0.00
Meningeal Cells, donor2	11573-120E7	121.92	16.29	1.32	0.44	0.44	2.64	0.00	1.32	0.00	0.00
Meningeal Cells, donor3	11654-122E7	204.90	18.17	2.69	1.14	4.48	3.18	0.00	0.90	0.33	0.00
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	158.55	9.70	2.57	0.57	3.99	2.28	0.57	1.14	0.86	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	134.04	9.76	1.61	1.61	2.01	0.91	0.00	0.60	0.50	0.00
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	47.31	3.94	0.00	1.31	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	98.11	10.47	1.31	0.00	2.62	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	134.19	13.63	0.72	2.15	2.15	0.72	0.00	0.72	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	169.20	15.46	3.39	2.12	1.91	1.06	0.00	0.64	1.69	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	164.37	16.59	0.50	2.01	2.01	1.01	0.00	0.50	0.50	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	161.52	10.11	1.10	1.10	2.42	2.20	0.44	1.32	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	127.85	10.23	3.65	0.00	2.92	0.73	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	128.70	19.03	0.20	1.43	3.07	2.05	0.41	0.61	0.00	0.41
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	73.41	8.86	0.69	0.69	0.55	1.52	0.42	0.83	0.00	0.55
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	96.65	4.46	2.60	2.60	0.00	0.00	0.00	1.12	0.37	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	129.73	5.53	2.50	1.45	1.45	0.53	0.00	1.18	0.13	0.00
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	100.30	8.90	0.89	1.78	0.89	0.30	0.00	0.30	0.30	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	25.69	0.00	0.00	0.00	0.00	0.00	0.00	2.34	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	170.35	18.57	1.28	1.92	6.40	1.28	0.00	2.56	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	175.80	7.80	2.84	1.77	1.42	1.06	0.00	0.71	0.00	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	91.00	7.51	1.56	0.63	0.63	1.25	0.00	0.63	0.00	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	116.84	8.71	1.45	1.45	2.18	1.45	0.00	1.45	1.45	0.00
Mesothelial Cells, donor1	11247-116E5	148.50	8.22	2.39	2.39	1.06	0.80	0.00	0.80	1.06	0.00
Mesothelial Cells, donor2	12156-128G5	116.11	12.01	2.50	1.00	3.50	1.00	0.00	1.50	0.50	0.00
Mesothelial Cells, donor3	11402-118D7	88.60	7.08	1.01	1.52	0.87	0.51	0.00	0.87	0.58	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	35.11	2.70	0.00	1.35	0.00	0.00	0.00	0.00	0.00	2.70
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	36.20	1.97	0.49	0.25	0.25	0.25	0.25	0.25	0.00	1.48
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	58.01	4.12	1.47	0.59	0.29	0.88	0.88	0.29	0.00	0.29
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	24.20	3.46	0.00	0.00	0.00	0.00	3.46	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	24.49	2.17	0.31	0.00	0.62	0.00	0.31	0.31	0.00	0.31
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	39.62	4.36	1.04	0.83	0.00	0.21	3.32	0.00	0.21	0.83
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	27.79	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	35.79	3.50	1.00	0.50	0.50	0.25	1.00	1.75	0.00	1.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	39.10	2.79	0.47	0.47	0.47	0.00	1.40	0.00	0.00	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	77.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	31.70	2.03	0.20	0.20	0.41	0.20	1.63	0.00	0.20	0.81
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	45.54	1.58	0.79	0.40	0.40	0.79	3.56	0.40	0.79	0.79
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	34.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	29.20	0.88	0.00	0.00	0.00	0.88	0.88	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	58.51	5.32	0.38	0.76	0.38	0.76	2.28	0.38	0.00	1.14
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	17.11	2.63	1.32	0.00	0.00	0.00	0.00	0.00	0.00	1.32
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	23.56	1.27	0.42	0.00	0.00	0.00	1.49	0.00	0.00	0.42
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	20.26	3.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	215.66	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	20.27	1.79	0.30	0.00	0.00	0.00	0.60	0.30	0.00	0.60
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	28.50	8.38	0.00	0.00	0.00	0.00	0.00	0.00	1.68	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	23.58	1.25	0.50	0.25	0.25	0.00	0.25	0.25	0.25	1.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	49.20	2.85	0.48	0.71	0.48	0.00	1.43	0.00	0.00	0.48
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	22.67	3.87	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.66
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	25.10	1.84	0.23	0.46	0.00	0.23	0.00	0.00	0.00	0.69
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	39.54	4.42	0.63	0.63	0.63	0.00	1.05	0.21	0.00	0.84
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	28.33	2.65	0.20	0.20	0.41	0.20	0.82	0.41	0.00	0.41
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	25.74	1.50	0.21	0.43	0.21	0.00	0.43	0.00	0.00	0.86
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	33.12	2.00	0.44	0.22	1.11	0.22	1.56	0.22	0.22	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	10.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	18.84	1.10	0.00	0.44	0.00	0.22	0.22	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	23.32	2.53	0.51	0.51	0.00	0.00	0.51	0.00	0.00	1.01
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	18.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	17.94	1.36	0.27	0.27	0.27	0.00	0.27	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	28.23	4.12	0.29	0.59	0.00	0.00	0.88	0.29	0.00	1.47
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	18.54	3.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	23.55	2.40	0.48	0.48	0.96	0.00	1.44	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	45.23	3.20	0.40	0.80	0.80	0.00	0.80	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	13.71	0.00	0.00	0.00	0.00	0.00	0.00	1.37	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	31.54	2.50	1.00	0.50	0.00	0.50	0.50	0.50	0.00	0.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	26.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	20.39	6.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	17.95	1.75	0.44	0.44	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	22.07	2.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	13.45	3.84	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	27.77	2.73	0.50	0.00	0.00	0.00	0.25	0.00	0.00	0.25
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	23.66	2.09	0.00	0.70	0.00	0.00	0.00	0.00	0.00	0.70
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	24.31	2.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	28.38	2.05	0.34	1.03	0.00	0.00	0.00	0.34	0.00	0.68
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	23.63	2.19	0.44	0.00	0.44	0.44	0.44	0.00	0.44	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	14.20	2.84	0.00	0.36	0.36	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	24.13	2.24	0.56	0.00	0.56	0.28	0.56	0.00	0.00	0.28
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	22.03	2.49	0.00	0.00	0.00	0.00	0.83	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	18.65	4.08	0.00	0.00	1.17	0.00	0.00	0.00	0.00	1.17
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	20.21	1.81	0.30	0.60	0.30	0.00	0.60	0.30	0.00	0.60
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	27.97	0.83	0.83	0.00	0.83	0.00	0.83	0.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	28.88	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	12.93	0.00	0.00	0.00	0.92	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	27.89	2.85	1.71	1.14	0.00	0.00	0.00	0.57	0.00	1.14
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	16.86	2.21	0.41	0.14	0.28	0.00	0.14	0.00	0.14	0.28
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	17.62	1.81	0.26	1.04	0.26	0.00	0.00	0.00	0.26	0.52
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	24.45	2.14	0.00	0.86	0.00	0.00	0.00	0.00	0.43	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	19.06	4.45	0.00	0.00	0.64	0.00	0.00	0.64	0.64	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	14.41	2.94	0.53	0.27	0.00	0.00	0.00	0.00	0.00	0.80
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	28.14	4.79	0.60	0.90	0.60	0.30	0.90	0.60	0.60	0.60
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	13.98	2.12	0.28	0.00	0.14	0.00	0.14	0.14	0.00	0.28
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	24.84	2.23	0.00	0.32	0.64	0.64	0.32	0.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	33.83	2.65	0.66	0.22	0.44	0.00	0.44	0.00	0.22	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	15.17	3.03	0.38	0.00	1.14	0.00	0.00	0.38	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	14.77	1.70	0.00	0.57	0.28	0.00	0.28	0.00	0.28	0.85
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	21.38	2.21	0.98	0.49	0.49	0.25	0.49	0.98	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	9.12	0.65	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	14.70	1.76	0.29	0.59	0.00	0.00	0.29	0.59	0.00	0.59
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	31.14	3.17	0.58	0.58	0.29	0.29	0.29	0.58	0.29	0.29
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	23.08	3.71	1.24	0.00	0.41	0.41	0.82	0.00	0.41	0.82
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	13.70	2.08	0.30	0.89	0.00	0.60	0.89	0.00	0.00	0.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	15.07	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	7.53
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	10.69	5.35	0.00	0.00	1.78	0.00	0.00	1.78	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	30.56	0.99	0.33	0.66	0.00	0.00	0.66	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	18.94	1.05	0.00	0.00	0.00	0.00	1.05	0.00	0.00	1.05
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	31.63	2.17	0.59	0.00	0.20	0.20	0.99	0.20	0.00	0.20
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	34.46	2.79	0.00	0.00	0.00	0.00	1.86	0.00	0.00	0.93
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	22.16	1.50	0.38	0.00	0.75	0.00	1.50	0.00	0.38	1.13
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	30.10	1.86	0.00	0.27	0.27	0.27	0.00	0.00	0.00	0.80
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	15.04	0.68	0.11	0.11	0.11	0.23	0.45	0.00	0.00	0.68
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	20.63	1.47	0.74	0.74	0.00	0.00	0.74	0.00	0.00	0.74
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	23.08	1.83	0.00	0.37	0.37	0.00	0.00	0.73	0.00	0.73
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	26.45	3.11	1.56	0.00	0.00	0.00	1.56	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	24.58	1.07	0.53	0.00	1.07	0.00	3.21	0.00	0.00	3.21
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	15.46	3.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	25.25	0.00	0.00	0.00	1.01	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	34.15	2.95	0.42	0.00	0.00	0.42	2.11	0.00	0.00	0.84
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	40.86	4.09	0.00	0.00	0.00	1.36	0.00	1.36	0.00	2.72
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	43.87	3.18	0.00	0.00	1.27	0.00	2.54	0.64	0.00	3.18
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	29.96	1.62	0.00	0.00	0.81	0.00	0.81	0.81	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	48.33	1.51	0.00	1.51	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	11.42	0.00	0.00	0.00	0.00	0.00	0.00	5.71	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	88.09	16.31	0.00	3.26	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	38.02	9.50	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	112.94	0.00	0.00	0.00	12.55	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	169.12	11.63	1.29	2.37	2.59	0.86	0.00	1.08	0.43	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	139.01	13.07	1.05	1.57	1.05	0.52	0.52	0.52	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	242.30	47.39	1.33	2.00	6.67	2.00	0.00	0.67	0.67	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	268.37	42.15	0.42	1.25	4.59	0.83	0.42	0.42	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	142.80	16.73	0.95	1.33	1.71	0.57	1.14	0.19	0.19	0.00
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	94.16	25.53	1.60	0.00	4.79	0.00	1.60	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	198.54	27.88	0.00	1.36	4.08	0.00	0.68	2.04	0.68	0.68
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	143.34	11.03	1.84	1.84	1.84	5.51	0.00	3.68	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	283.77	28.04	1.26	1.67	5.02	0.84	0.00	2.09	1.67	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	241.50	27.20	0.70	1.39	3.25	1.39	0.23	0.00	0.00	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	348.86	30.81	1.62	1.35	4.59	0.27	0.27	0.81	1.35	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	131.19	11.56	0.84	1.05	1.68	1.05	0.63	1.05	0.84	0.21
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	200.42	22.27	0.00	0.00	0.00	0.00	11.13	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	205.99	24.82	0.50	0.50	3.97	0.99	0.50	0.00	1.49	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	143.73	11.10	0.54	1.08	1.35	0.81	0.00	0.27	0.81	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	205.37	17.00	0.23	0.68	2.04	0.68	0.45	0.23	0.45	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	236.79	23.52	0.49	0.82	3.76	0.49	0.65	0.33	1.31	0.16
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	91.67	12.03	0.91	0.91	0.18	0.00	0.91	0.73	0.73	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	228.62	20.69	0.00	0.00	3.18	0.53	1.06	0.00	3.71	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	220.91	20.41	0.60	0.00	4.80	0.00	0.00	0.00	4.20	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	69.25	7.22	0.33	0.66	0.00	0.33	0.33	0.33	0.33	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	172.87	18.38	0.81	0.65	2.11	0.98	0.00	0.16	0.81	0.33
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	104.77	11.99	1.06	0.00	0.71	0.18	0.00	0.18	0.71	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	232.07	16.88	1.41	1.41	2.11	0.70	0.00	0.70	2.11	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	233.07	20.69	0.00	0.46	0.92	0.46	0.00	0.46	2.30	0.46
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	317.81	26.67	2.25	0.32	3.21	1.29	0.32	1.61	2.57	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	77.60	6.90	0.00	0.69	0.00	0.69	0.69	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	149.18	12.64	0.00	0.00	0.00	0.00	2.53	0.00	2.53	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	92.68	9.80	0.89	0.45	1.78	0.22	0.67	0.22	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	251.07	27.94	0.85	0.42	0.85	0.00	0.42	0.42	0.85	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	110.84	13.29	0.00	0.00	0.71	0.24	0.24	0.00	0.47	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	397.48	37.34	0.43	1.72	3.00	1.72	0.43	0.43	2.58	0.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	126.39	0.00	0.00	0.00	9.03	0.00	9.03	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	250.58	23.99	1.33	1.00	4.33	0.67	0.33	1.33	4.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	97.39	12.62	1.35	0.90	1.35	0.90	0.45	0.00	0.45	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	223.40	23.81	0.40	0.00	2.78	0.00	1.19	1.19	0.40	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	229.38	22.29	0.93	0.93	3.71	0.93	0.93	1.86	1.86	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	233.83	28.76	1.14	2.27	2.27	3.03	0.38	0.38	0.76	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	190.97	14.34	0.00	0.98	1.63	0.00	0.00	1.30	0.65	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	177.36	20.05	0.87	1.31	2.61	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	99.50	11.76	1.81	0.45	2.71	0.00	0.90	0.00	0.45	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	282.21	31.75	0.88	0.00	1.76	0.00	0.88	2.65	0.88	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	242.00	19.95	1.33	1.33	1.33	0.00	0.00	0.00	1.99	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	292.67	28.27	0.99	0.00	2.48	0.50	0.00	0.99	2.98	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	196.39	20.67	0.38	2.30	3.06	1.15	0.38	0.00	1.15	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	101.32	6.35	0.30	1.51	0.60	0.60	0.60	0.30	0.30	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	114.05	12.60	2.21	0.88	1.77	0.66	0.88	0.44	0.66	0.44
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	225.66	25.07	0.68	2.03	4.07	1.36	0.00	0.68	1.36	0.68
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	132.85	15.33	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	294.48	31.70	2.44	0.00	3.66	0.61	0.00	0.00	0.61	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	202.06	24.86	0.31	0.94	4.41	0.31	0.31	0.63	0.00	0.31
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	200.96	23.00	0.61	0.91	1.21	0.00	0.00	0.30	2.12	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	235.76	22.15	2.37	0.00	2.37	0.79	0.00	0.79	1.58	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	68.02	9.07	2.27	3.40	4.53	1.13	0.00	0.00	1.13	1.13
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	80.93	5.06	0.00	0.00	5.06	0.00	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	153.92	16.15	1.37	0.75	5.22	1.12	1.74	0.25	0.75	0.50
Myoblast, donor2	11322-117D8	162.83	20.52	1.73	2.49	2.88	1.15	1.15	0.58	0.19	0.38
Myoblast, donor3	11398-118D3	216.26	20.18	3.20	1.51	6.22	2.69	4.71	0.67	0.84	1.18
NK T cell leukemia cell line:KHYG-1	10777-110G3	17.51	0.88	0.29	0.15	0.00	0.15	0.00	0.15	0.00	0.15
Natural Killer Cells, donor1	11230-116C6	7.07	0.62	0.00	0.31	0.00	0.00	0.31	0.00	0.00	0.92
Natural Killer Cells, donor2	11311-117C6	8.44	1.21	0.00	0.00	0.00	0.00	0.30	0.00	0.30	0.00
Natural Killer Cells, donor3	11387-118C1	8.47	0.55	0.00	0.18	0.37	0.00	0.18	0.00	0.37	0.18
Neural stem cells, donor1	11275-116H6	500.49	37.75	7.98	3.99	11.61	9.44	20.32	1.81	9.07	3.99
Neural stem cells, donor2	11352-117H2	333.14	11.55	3.85	0.00	7.70	13.48	3.85	0.00	1.93	1.93
Neurons, donor1	11494-119E9	180.93	23.90	5.69	4.55	15.93	15.93	14.79	1.14	0.00	0.00
Neurons, donor2	11574-120E8	153.23	12.33	4.40	0.66	4.84	22.02	11.01	1.98	1.32	1.32
Neurons, donor3	11655-122E8	233.50	30.42	1.64	0.82	6.58	23.02	14.80	0.82	0.00	0.82
Neutrophils, donor1	11233-116C9	12.06	2.78	0.93	0.93	0.00	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	8.70	5.80	0.00	0.00	0.00	0.00	0.00	0.00	0.00	2.90
Neutrophils, donor3	11390-118C4	13.44	0.61	0.00	0.61	0.00	0.00	1.22	0.00	0.00	1.22
Nucleus Pulposus Cell, donor1	11252-116F1	123.48	10.80	0.59	1.54	1.19	1.19	0.71	0.59	0.12	0.24
Nucleus Pulposus Cell, donor2	11409-118E5	102.89	9.12	0.98	1.30	0.00	0.33	0.00	0.33	0.33	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	72.20	8.02	0.40	0.60	0.20	0.40	0.60	0.00	0.00	0.20
Olfactory epithelial cells, donor1	11933-125I7	137.93	12.66	1.10	1.10	1.24	0.14	0.00	0.55	0.14	0.00
Olfactory epithelial cells, donor2	11934-125I8	173.98	21.42	1.30	0.43	2.46	1.01	0.00	0.87	0.29	0.00
Olfactory epithelial cells, donor3	11935-125I9	137.11	14.87	1.59	0.91	1.82	0.91	0.00	0.57	0.23	0.00
Olfactory epithelial cells, donor4	11936-126A1	189.54	14.41	2.53	2.34	0.97	0.39	0.00	0.78	0.78	0.00
Oligodendrocyte - precursors, donor1	11496-119F2	140.22	9.03	3.01	4.21	0.00	0.00	0.00	2.41	0.60	0.00
Osteoblast - differentiated, donor1	11276-116H7	112.09	9.57	1.06	0.85	1.06	1.70	0.64	0.43	2.34	0.64
Osteoblast - differentiated, donor2	11353-117H3	148.60	11.43	3.43	2.29	3.43	2.29	0.00	1.14	4.57	0.00
Osteoblast - differentiated, donor3	11425-118G3	113.59	4.97	1.24	1.86	1.86	0.62	0.00	0.00	3.10	0.00
Osteoblast, donor1	11277-116H8	136.22	6.45	2.35	1.17	3.52	2.15	0.00	1.17	0.98	0.00
Osteoblast, donor2	11354-117H4	252.13	22.47	1.40	0.70	4.21	2.11	0.00	2.11	1.40	0.00
Osteoblast, donor3	11426-118G4	154.63	16.53	2.67	3.73	2.49	1.42	0.18	1.07	0.36	0.00
Pancreatic stromal cells, donor1	11249-116E7	127.70	12.47	1.01	0.84	1.85	1.26	0.42	0.42	2.19	0.17
Pericytes, donor1	11491-119E6	56.63	4.12	1.22	0.56	0.00	0.22	0.00	0.11	0.22	0.00
Pericytes, donor2	11571-120E5	84.21	9.96	1.81	0.45	0.45	0.68	0.45	0.45	0.91	0.00
Pericytes, donor3	11652-122E5	136.72	13.02	3.05	1.02	2.64	1.63	0.00	1.63	0.00	0.20
Perineurial Cells, donor1	11499-119F5	151.34	8.25	2.15	3.05	1.36	1.47	0.23	1.36	0.23	0.23
Perineurial Cells, donor2	11579-120F4	198.93	14.72	2.02	1.38	4.69	2.21	0.18	1.56	0.37	0.18
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	19.44	1.27	0.64	0.00	0.00	0.00	5.74	0.00	0.32	8.92
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	21.06	1.47	0.24	0.24	0.49	0.00	3.67	0.49	0.00	5.39
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	13.59	1.29	0.39	0.26	0.39	0.00	2.33	0.26	0.00	8.15
Placental Epithelial Cells, donor1	11278-116H9	81.79	4.07	1.67	1.20	0.24	0.24	0.00	1.67	0.72	0.00
Placental Epithelial Cells, donor2	11355-117H5	133.07	15.52	3.33	1.11	1.11	1.11	0.00	1.11	2.22	0.00
Placental Epithelial Cells, donor3	11427-118G5	116.03	10.60	3.14	1.18	1.18	0.98	0.00	1.37	0.39	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	224.05	31.33	2.53	3.16	2.85	0.95	0.00	3.16	2.22	0.00
Preadipocyte - breast, donor1	11467-119B9	147.44	12.19	1.50	0.94	2.81	1.13	0.00	1.13	1.88	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	52.47	3.52	1.31	0.52	1.04	0.52	0.00	0.78	0.13	0.00
Preadipocyte - breast, donor2	11328-117E5	197.68	29.49	2.93	2.70	4.50	1.35	0.00	0.90	0.90	0.00
Preadipocyte - omental, donor1	11468-119C1	187.33	16.73	3.41	1.49	3.41	1.39	0.00	0.85	1.92	0.00
Preadipocyte - omental, donor2	11329-117E6	217.80	8.73	2.62	2.62	4.36	0.87	0.00	0.00	1.31	0.00
Preadipocyte - omental, donor3	11403-118D8	266.16	16.90	4.73	4.44	5.01	0.57	0.00	1.43	1.58	0.00
Preadipocyte - perirenal, donor1	11469-119C2	122.05	17.72	7.87	2.95	0.98	0.98	0.00	1.97	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	151.72	11.36	2.15	0.61	2.46	0.92	0.00	0.61	1.23	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	279.43	27.09	3.01	2.48	4.07	0.89	0.00	0.89	0.18	0.00
Preadipocyte - subcutaneous, donor3	11428-118G6	316.05	36.27	3.58	3.92	3.07	1.36	0.00	0.85	4.60	0.00
Preadipocyte - visceral, donor1	11280-116I2	251.22	17.98	1.58	1.49	4.01	1.96	0.00	0.37	1.77	0.00
Preadipocyte - visceral, donor2	11357-117H7	239.75	19.79	3.22	0.92	2.30	1.38	0.00	1.84	2.30	0.00
Preadipocyte - visceral, donor3	11429-118G7	169.38	21.53	1.99	0.73	1.46	1.25	0.00	0.63	1.88	0.00
Prostate Epithelial Cells (polarized), donor1	11253-116F2	54.31	2.72	3.32	1.66	0.91	1.96	0.00	1.06	1.21	0.00
Prostate Epithelial Cells, donor2	11331-117E8	133.38	13.81	2.30	2.17	4.06	1.76	0.00	1.49	2.98	0.00
Prostate Epithelial Cells, donor3	11404-118D9	86.22	5.76	2.27	1.35	0.61	0.31	0.00	0.49	1.35	0.00
Prostate Stromal Cells, donor1	11254-116F3	151.03	12.30	2.05	1.03	2.39	1.03	0.00	0.23	1.82	0.00
Prostate Stromal Cells, donor2	11332-117E9	130.53	11.30	2.15	0.36	1.08	1.08	0.00	0.54	0.90	0.00
Prostate Stromal Cells, donor3	11405-118E1	151.41	11.89	1.36	1.36	1.56	0.63	0.00	0.52	3.13	0.00
Renal Cortical Epithelial Cells, donor1	11516-119H4	96.72	3.28	4.38	2.19	1.82	0.00	0.36	2.19	0.36	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	107.02	5.96	4.09	2.01	0.83	0.42	0.14	2.36	0.21	0.00
Renal Epithelial Cells, donor1	11517-119H5	112.10	6.09	6.09	1.01	0.51	0.00	0.00	3.04	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	114.52	9.25	2.85	0.00	0.71	0.00	0.00	0.00	0.71	0.00
Renal Epithelial Cells, donor3	11678-122H4	113.80	7.30	3.81	1.16	1.27	0.42	0.00	3.07	0.21	0.00
Renal Glomerular Endothelial Cells, donor1	11514-119H2	173.62	14.30	10.89	7.49	0.00	2.04	1.36	2.04	1.36	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	127.49	11.45	2.83	3.64	0.40	0.94	0.54	1.48	0.13	0.27
Renal Glomerular Endothelial Cells, donor3	11675-122H1	155.85	19.54	3.77	3.77	3.77	1.55	0.89	1.78	0.00	0.44
Renal Glomerular Endothelial Cells, donor4	11783-124B1	206.95	15.31	5.99	3.33	0.67	0.00	0.00	3.99	0.67	0.00
Renal Mesangial Cells, donor1	11518-119H6	141.96	6.60	2.42	1.54	1.32	1.10	0.22	1.32	0.66	0.00
Renal Mesangial Cells, donor2	11598-120H5	131.67	12.54	3.76	2.51	1.88	0.63	0.63	1.88	1.25	0.00
Renal Mesangial Cells, donor3	11679-122H5	91.55	6.38	2.77	1.39	1.94	0.00	0.00	0.55	0.55	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	110.05	4.56	4.83	1.34	1.07	0.27	0.00	1.07	0.27	0.27
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	60.72	8.01	0.42	0.84	1.27	0.42	0.00	0.84	0.42	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	127.66	10.80	5.01	1.93	2.89	0.00	0.19	1.74	0.39	0.39
Retinal Pigment Epithelial Cells, donor0	11215-116A9	102.68	5.44	3.11	2.07	3.11	2.59	0.00	1.30	0.00	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	98.63	7.39	1.42	1.99	2.84	1.71	0.00	0.85	0.57	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	116.29	10.29	2.06	2.06	5.15	2.06	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	46.42	5.77	1.25	0.75	0.50	2.51	0.00	1.51	0.25	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	49.04	4.14	2.81	1.20	0.40	0.13	0.00	0.80	0.40	0.67
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	17.87	0.89	0.89	0.00	0.00	0.00	0.00	0.00	0.89	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	12.66	1.65	0.00	0.55	0.55	2.20	0.00	0.00	0.55	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	13.92	1.74	0.00	0.00	0.58	0.58	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	14.69	3.25	0.39	0.52	0.39	1.04	0.00	0.26	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	25.62	5.46	0.89	1.19	0.70	0.40	0.00	0.60	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	35.02	4.80	1.78	1.45	1.12	1.12	0.00	0.56	0.22	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	28.90	3.35	0.99	0.74	0.25	0.99	0.00	0.99	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	32.52	5.48	1.40	1.52	0.58	1.75	0.00	0.82	0.23	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	30.05	4.62	0.69	0.92	0.46	1.39	0.00	0.92	0.46	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	13.96	2.05	0.55	0.82	0.00	0.41	0.00	0.41	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	23.60	4.54	1.36	0.76	0.91	0.15	0.00	0.30	0.15	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	34.40	3.40	1.43	1.79	1.61	0.72	0.00	0.72	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	15.64	3.16	1.15	0.29	0.14	0.57	0.00	0.72	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	30.58	3.43	1.29	1.07	0.54	0.64	0.00	0.64	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	28.32	3.54	1.55	0.89	0.89	0.66	0.00	1.55	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	10.32	2.87	0.57	0.38	0.00	0.38	0.00	0.76	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	22.17	4.19	0.75	0.37	0.47	0.37	0.00	0.19	0.09	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	29.88	3.01	2.07	1.50	0.38	1.88	0.00	1.13	0.38	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	11.55	2.52	0.53	0.13	0.53	0.66	0.00	0.13	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	27.74	5.06	1.07	1.56	0.58	0.88	0.00	0.58	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	30.17	3.06	1.72	0.76	0.57	0.76	0.00	0.76	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	13.46	2.56	1.28	0.11	0.21	0.32	0.00	0.21	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	22.14	5.05	0.84	0.84	0.28	1.96	0.00	0.28	0.28	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	28.37	5.30	1.03	0.85	1.37	1.03	0.00	0.51	0.34	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	11.30	2.92	0.55	0.36	0.18	0.55	0.00	0.36	0.18	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	26.98	5.03	1.23	0.86	0.98	0.37	0.00	1.23	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	33.31	4.70	1.21	1.61	1.21	0.67	0.00	0.27	0.13	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	10.38	4.25	1.42	0.47	0.00	0.47	0.00	0.24	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	26.79	3.97	2.38	0.79	0.79	1.19	0.00	0.60	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	24.55	4.68	1.64	1.87	0.23	2.10	0.00	0.47	0.23	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	16.59	3.73	0.83	1.04	0.21	0.21	0.00	0.21	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	22.12	4.42	1.33	1.11	0.22	0.66	0.00	0.22	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	26.32	3.97	0.63	1.04	1.04	1.04	0.00	0.42	0.42	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	19.38	3.36	0.94	0.67	0.27	0.54	0.00	0.54	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	19.75	4.26	1.02	1.36	0.34	0.34	0.00	0.51	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	30.46	6.36	2.12	0.77	0.77	0.39	0.00	0.19	0.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	12.72	3.44	0.86	0.69	0.69	0.52	0.00	0.17	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	21.54	6.45	0.96	0.96	0.82	0.96	0.00	1.10	0.14	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	24.30	5.58	0.99	0.99	0.49	0.66	0.00	0.00	0.16	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	11.25	2.56	0.34	0.68	0.51	0.34	0.00	0.85	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	33.88	6.07	1.33	2.66	0.74	0.44	0.00	0.74	0.15	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	27.19	5.33	0.27	1.60	0.00	1.07	0.00	0.53	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	10.92	1.38	1.24	0.41	0.00	0.28	0.00	0.14	0.14	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	29.05	5.48	1.43	1.43	1.19	0.95	0.00	0.24	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	30.84	4.64	1.41	1.21	1.21	1.41	0.00	0.40	0.20	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	13.66	2.54	1.41	0.75	0.00	0.75	0.00	0.38	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	26.90	4.89	0.70	2.10	0.35	0.35	0.00	0.00	0.70	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	23.87	4.23	0.91	0.30	0.30	1.21	0.00	0.60	0.30	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	23.99	1.59	2.20	0.73	0.12	0.24	0.00	0.49	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	32.02	4.51	2.04	1.31	0.87	1.16	0.00	0.44	0.15	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	25.55	6.08	1.83	0.61	1.22	0.61	0.00	0.61	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	13.56	2.71	1.81	0.60	0.30	0.30	0.00	0.90	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	25.79	3.85	1.81	1.13	0.23	0.45	0.00	0.45	0.90	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	29.06	2.10	1.50	1.80	0.60	0.00	0.00	1.20	1.20	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	12.63	2.72	0.94	0.47	0.35	1.06	0.00	1.18	0.59	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	23.27	2.56	0.64	1.71	0.64	1.92	0.00	0.85	0.43	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	32.45	3.00	1.80	1.80	1.20	0.00	0.00	0.00	1.20	0.00
Schwann Cells, donor1	11498-119F4	121.12	15.23	2.63	1.50	0.94	0.94	0.19	0.94	0.75	0.00
Schwann Cells, donor2	11578-120F3	125.89	6.80	3.40	0.00	3.40	3.40	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	141.96	18.84	1.97	1.75	2.85	2.41	0.66	1.31	0.22	0.22
Sebocyte, donor1	11220-116B5	221.30	14.79	2.74	3.29	2.19	1.64	0.00	0.55	2.74	0.00
Sebocyte, donor2	11301-117B5	115.35	12.41	0.92	0.46	1.84	0.46	0.00	0.92	0.46	0.00
Sebocyte, donor3	11378-118B1	128.20	7.42	0.62	0.82	0.62	0.00	0.00	0.21	1.24	0.00
Sertoli Cells, donor1	11255-116F4	275.00	14.91	8.28	1.66	1.66	3.31	0.00	4.97	3.31	0.00
Sertoli Cells, donor2	11333-117F1	197.71	28.24	2.82	2.82	0.00	0.00	0.00	0.00	8.47	0.00
Skeletal Muscle Cells, donor1	11281-116I3	176.66	9.94	4.13	2.46	3.08	1.94	3.70	1.14	2.02	0.18
Skeletal Muscle Cells, donor2	11358-117H8	56.38	8.67	0.00	0.72	0.72	0.00	1.45	0.72	1.45	0.00
Skeletal Muscle Cells, donor3	11430-118G8	98.65	14.21	1.67	1.67	0.84	0.84	1.67	0.00	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	104.62	9.43	1.26	0.63	1.10	1.10	0.31	0.47	0.63	0.00
Skeletal Muscle Cells, donor5	11455-119A6	101.23	12.63	1.34	0.89	1.19	0.74	0.00	0.74	0.74	0.00
Skeletal Muscle Cells, donor6	11459-119B1	122.97	15.39	0.77	1.39	2.77	0.77	1.69	0.92	0.31	0.00
Skeletal Muscle Satellite Cells, donor1	11240-116D7	135.83	11.09	0.63	1.01	2.27	2.52	0.13	0.25	1.01	0.00
Skeletal Muscle Satellite Cells, donor2	11321-117D7	125.00	11.42	1.71	0.29	2.71	1.28	0.43	0.29	1.00	0.00
Skeletal Muscle Satellite Cells, donor3	11397-118D2	174.81	13.89	2.58	1.19	3.57	1.49	0.79	0.69	0.79	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	239.95	23.59	3.79	1.94	5.64	2.95	9.77	0.93	0.67	0.51
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	105.67	13.03	0.72	1.45	2.17	0.72	1.45	0.00	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	102.79	14.59	0.96	1.65	1.24	1.51	0.69	0.83	0.28	0.28
Skin - palm, donor1	10286-104F7	8.06	2.69	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	97.45	10.24	1.44	1.15	1.30	0.58	0.00	0.43	1.44	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	10.63	3.27	1.64	0.00	0.82	0.00	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	86.21	11.55	1.56	0.65	1.17	0.65	0.00	0.91	0.65	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	96.47	7.37	3.61	1.67	1.95	1.39	0.00	0.56	1.53	0.00
Small Airway Epithelial Cells, donor2	11334-117F2	88.90	9.56	2.39	1.27	1.27	0.70	0.00	0.98	1.13	0.00
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	41.02	3.17	0.63	0.63	0.21	0.00	0.00	0.21	0.00	0.00
Small Airway Epithelial Cells, donor3	11406-118E2	112.50	8.62	3.75	1.80	1.05	0.37	0.00	0.97	2.32	0.00
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	202.12	17.28	3.70	2.16	1.54	1.85	0.00	1.23	0.93	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	54.03	2.89	0.67	0.44	0.22	0.00	0.00	0.22	0.67	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	235.72	11.76	4.11	3.53	2.35	0.00	0.00	0.59	1.76	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	108.06	7.96	1.55	1.33	2.43	0.44	0.22	1.10	0.44	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	121.28	6.69	1.97	0.79	1.97	0.79	0.00	0.39	0.39	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	247.99	16.22	2.32	2.32	3.09	1.55	0.00	0.00	0.77	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	111.08	6.00	2.00	1.00	1.00	1.00	0.00	1.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	178.06	11.44	2.66	0.67	2.66	0.80	0.00	0.93	2.13	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	155.60	19.06	1.11	1.55	1.33	2.66	0.00	0.89	1.99	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	116.51	15.24	1.41	1.15	2.30	1.15	0.00	0.38	1.79	0.00
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	86.61	5.54	0.98	2.93	1.30	0.33	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	107.50	5.61	1.18	0.89	1.18	3.25	0.59	0.00	1.48	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	118.59	12.10	1.28	1.28	1.28	0.71	0.00	0.43	1.00	0.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	165.11	9.92	1.46	0.81	2.11	0.65	0.00	0.65	0.33	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	58.45	6.09	0.30	0.61	1.22	0.30	0.00	0.30	0.30	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	93.95	6.82	1.26	0.76	1.01	0.76	0.25	0.25	0.76	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	97.93	30.60	0.00	0.00	6.12	0.00	0.00	0.00	6.12	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	95.84	14.31	2.38	0.48	1.43	0.00	0.00	2.38	0.95	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	115.18	7.96	1.62	1.77	2.95	1.62	0.15	0.59	0.29	0.00
Smooth Muscle Cells - Colonic, donor2	11320-117D6	111.92	12.48	1.94	1.08	1.29	0.43	0.00	1.08	0.65	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	136.34	12.39	1.78	1.05	3.36	1.57	0.00	0.52	0.21	0.00
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	150.19	11.60	1.55	0.62	2.63	0.46	0.00	0.31	1.08	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	120.72	17.25	2.16	0.00	0.00	0.00	0.00	3.23	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	85.17	14.05	1.20	0.90	1.20	0.60	0.00	0.60	0.30	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	133.83	5.46	1.71	1.37	1.37	2.39	0.00	1.37	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	90.78	5.81	0.86	0.79	0.86	0.71	0.00	0.63	0.08	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	211.25	16.51	3.42	2.52	3.22	1.51	0.00	1.41	15.20	0.20
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	215.49	22.76	4.10	2.96	3.41	0.46	0.00	1.14	0.91	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	86.95	10.26	0.60	0.60	0.60	0.60	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	172.73	14.84	2.38	0.79	2.91	2.38	0.26	0.53	0.00	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	132.49	9.45	1.20	0.80	1.07	1.46	0.13	0.67	1.86	0.13
Smooth Muscle Cells - Prostate, donor2	11335-117F3	184.20	16.28	1.50	1.25	3.38	0.63	0.13	0.50	4.26	0.00
Smooth Muscle Cells - Prostate, donor3	11465-119B7	83.71	4.57	0.76	0.76	1.01	0.25	0.00	0.25	0.76	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	229.18	19.30	2.56	1.51	2.86	1.96	0.00	0.75	1.06	0.00
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	115.53	7.50	3.00	3.00	0.00	0.75	0.00	0.75	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	148.60	28.43	5.17	0.00	0.00	1.29	0.00	0.00	1.29	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	233.00	12.56	2.33	1.40	2.33	0.00	0.00	0.93	1.86	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	189.84	23.73	6.06	2.02	3.53	1.51	0.00	3.03	1.01	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	138.83	15.98	1.57	0.94	2.19	1.88	0.00	0.31	0.63	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	104.72	6.49	0.29	0.59	1.18	0.00	0.00	0.00	0.29	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	122.21	6.83	1.00	1.08	2.42	1.00	0.00	0.25	0.08	0.00
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	86.89	5.61	0.47	0.47	0.00	1.40	0.00	0.47	0.47	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	156.87	9.79	3.31	2.16	2.30	0.86	0.00	1.01	1.30	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	127.99	12.75	1.02	2.29	1.02	1.02	0.00	0.51	0.00	0.25
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	88.19	11.85	1.69	0.75	0.75	1.69	0.00	0.94	0.56	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	165.46	11.88	1.12	0.56	3.21	1.68	0.00	0.70	0.42	0.00
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	153.92	6.03	1.42	1.59	1.17	0.25	0.00	1.09	0.17	0.08
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	53.81	1.90	0.00	2.38	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	126.00	7.34	1.96	1.47	0.98	1.71	0.00	0.73	0.49	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	137.43	9.72	0.66	1.55	0.66	1.55	0.00	0.66	1.33	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	79.58	4.68	0.00	0.29	1.17	1.46	0.00	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	120.50	12.63	1.17	0.78	1.17	0.39	0.00	0.39	0.97	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	85.68	10.58	1.32	0.53	2.12	0.00	0.00	0.26	0.53	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	63.97	6.70	0.00	0.37	1.12	0.37	0.00	0.37	0.37	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	126.13	11.86	0.36	0.00	0.36	0.36	0.00	0.36	0.72	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	107.88	10.22	1.14	0.00	2.84	0.28	0.00	0.57	0.28	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	102.80	15.75	1.18	0.79	1.58	1.18	0.00	0.39	0.79	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	82.53	7.36	0.51	0.00	1.78	1.52	0.00	0.00	2.29	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	107.82	7.19	1.20	0.00	0.80	0.40	0.00	0.00	0.80	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	103.67	5.85	0.42	0.84	0.84	0.42	0.00	0.42	0.00	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	67.84	4.58	0.00	0.00	0.46	0.46	0.00	0.00	0.00	0.00
Synoviocyte, donor1	11291-117A4	150.31	13.30	3.03	1.35	2.52	1.35	0.17	1.35	1.51	0.00
Synoviocyte, donor2	11368-117I9	129.24	12.91	1.68	1.84	1.68	0.50	0.00	0.00	2.68	0.00
Synoviocyte, donor3	11440-118H9	94.06	6.70	0.45	0.45	0.45	0.67	0.00	0.22	0.67	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	228.33	16.44	3.57	2.50	4.65	1.07	0.36	1.43	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	101.08	3.96	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	181.30	13.20	3.24	1.16	3.24	0.46	0.00	1.62	0.23	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	72.97	4.09	1.22	0.79	0.43	0.36	0.00	0.43	0.14	0.00
Tracheal Epithelial Cells, donor2	11369-118A1	69.97	4.64	1.16	0.39	1.93	0.00	0.00	0.39	0.00	0.77
Tracheal Epithelial Cells, donor3	11441-118I1	35.51	8.02	1.15	0.00	0.00	0.57	0.00	1.15	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	59.79	1.48	2.71	1.48	0.25	0.25	0.12	1.23	0.25	0.49
Urethra, donor2	10319-105A4	64.74	1.80	1.80	1.80	1.80	1.80	0.00	3.60	1.80	0.00
Urothelial Cells, donor1	11520-119H8	100.95	4.52	2.13	1.06	0.27	0.53	0.00	0.53	0.53	0.00
Urothelial Cells, donor2	11600-120H7	62.09	3.61	1.20	0.80	0.00	0.40	0.00	0.80	0.40	0.00
Urothelial Cells, donor3	11681-122H7	77.24	6.65	2.06	0.92	0.69	0.00	0.00	1.15	0.23	0.00
Urothelial cells, donor0	11216-116B1	101.42	4.46	3.34	1.11	0.45	0.22	0.00	1.34	0.00	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	25.80	2.67	0.00	0.89	0.00	0.00	13.35	0.00	0.00	8.01
Whole blood (ribopure), donor090309, donation2	12180-129A2	25.73	1.43	1.43	1.43	0.00	0.00	7.15	0.00	0.00	14.30
Whole blood (ribopure), donor090309, donation3	12181-129A3	41.76	0.68	1.37	0.00	0.00	0.68	5.48	0.00	0.00	10.27
Whole blood (ribopure), donor090325, donation1	12176-128I7	39.25	0.34	0.34	0.34	0.00	0.00	7.58	1.03	0.00	8.61
Whole blood (ribopure), donor090325, donation2	12177-128I8	33.12	0.00	0.58	1.16	1.16	0.00	6.39	0.58	0.58	8.72
Whole blood (ribopure), donor090612, donation1	12182-129A4	19.78	1.04	1.04	1.04	0.00	0.00	7.29	1.04	0.00	9.37
Whole blood (ribopure), donor090612, donation2	12183-129A5	22.03	1.84	0.92	0.00	0.92	0.00	5.51	0.92	0.00	7.34
Whole blood (ribopure), donor090612, donation3	12184-129A6	24.65	2.74	0.00	0.00	0.00	0.00	11.87	0.00	0.00	10.95
Wilms' tumor cell line:G-401	10809-111A8	84.63	7.03	2.10	1.36	2.34	1.97	0.00	2.10	0.25	0.00
Wilms' tumor cell line:HFWT	10597-108E3	51.92	2.64	0.00	0.00	0.00	1.76	0.00	0.88	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	115.36	15.64	1.68	1.96	1.96	0.28	0.00	0.56	0.00	0.00
achilles tendon, donor2	10292-104G4	33.06	4.13	2.07	2.07	2.07	0.00	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	84.39	5.35	1.27	1.02	2.29	0.76	0.00	2.29	0.51	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	110.75	7.20	1.86	2.09	1.63	4.88	0.00	1.39	0.70	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	97.46	6.41	6.53	2.14	2.73	4.87	0.00	5.22	0.36	0.00
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	109.39	5.99	2.99	2.18	3.27	4.90	0.00	1.36	1.09	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	125.08	24.17	6.75	6.75	7.03	7.03	17.43	4.78	0.56	8.43
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	41.03	6.98	1.27	1.48	1.06	2.11	0.42	1.48	0.00	0.63
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	90.10	16.06	5.44	2.72	5.99	5.17	19.05	3.27	0.27	23.41
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	58.16	2.64	0.88	0.44	1.32	1.76	7.49	0.88	0.00	11.46
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	80.04	6.53	1.23	0.82	1.23	2.04	5.72	1.23	0.00	6.13
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	79.99	2.72	1.16	0.78	0.39	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	23.00	3.31	1.29	0.92	0.55	0.37	0.00	0.55	0.37	0.18
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	19.50	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	64.83	14.64	2.32	1.39	2.32	0.46	0.93	3.02	0.46	0.70
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	25.89	2.07	0.26	0.26	0.00	0.26	0.00	0.26	0.00	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	30.69	4.38	0.58	0.29	0.00	0.00	0.00	0.29	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	22.31	2.32	1.39	0.00	0.46	0.93	0.00	0.93	0.00	0.93
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	24.26	2.47	0.41	0.00	0.00	0.00	0.00	0.82	0.41	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	13.81	4.60	0.92	0.31	0.61	0.00	0.31	0.61	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	23.90	2.56	0.43	0.43	0.00	0.85	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	24.26	1.82	0.61	0.61	0.00	0.30	0.00	0.91	0.30	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	27.20	2.65	1.68	0.24	0.48	1.20	0.00	0.24	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	27.17	3.79	0.89	0.22	0.22	0.45	0.00	0.00	0.00	0.45
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	21.01	2.00	0.67	0.67	0.33	0.33	0.00	0.33	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	48.31	5.57	0.00	0.00	1.86	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	46.33	4.90	0.00	0.75	1.51	0.38	0.00	0.00	0.00	0.38
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	100.75	20.06	2.18	4.36	5.23	3.93	57.13	0.44	1.31	29.66
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	31.87	7.50	0.00	0.00	1.87	0.00	0.00	0.00	0.00	3.75
adenocarcinoma cell line:IM95m	10796-110I4	56.52	4.24	0.71	1.18	0.24	0.47	0.00	0.47	0.24	0.00
adipose tissue, adult, pool1	10010-101C1	54.91	0.62	1.71	0.78	0.31	0.31	0.31	0.31	0.31	0.62
adipose, donor1	10184-103D4	53.95	3.52	1.17	0.59	1.17	0.00	0.00	1.17	7.04	0.00
adipose, donor2	10185-103D5	64.88	1.22	2.43	1.62	0.00	0.00	0.00	0.41	1.62	0.00
adipose, donor3	10186-103D6	82.23	5.45	1.91	2.72	1.36	2.45	0.00	0.82	4.63	0.00
adipose, donor4	10187-103D7	132.61	23.40	4.33	0.87	6.07	0.87	0.00	0.87	3.47	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	45.29	9.63	0.79	0.47	2.84	0.16	0.00	0.63	0.16	0.00
adrenal gland, adult, pool1	10081-102A9	65.48	3.64	3.64	7.28	0.00	0.00	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	8.00	0.13	0.13	0.00	0.00	0.00	0.00	0.00	0.00	0.00
alveolar cell carcinoma cell line:SW 1573	10708-109H6	115.05	4.29	4.29	3.57	0.36	2.86	0.00	2.14	0.71	0.00
amniotic membrane cells, donor1	12235-129G3	73.96	4.87	3.01	1.39	1.62	0.23	0.00	1.62	0.00	0.00
amniotic membrane cells, donor2	12236-129G4	218.75	15.21	5.07	4.73	2.37	1.69	0.34	4.40	2.37	1.01
amniotic membrane cells, donor3	12237-129G5	47.73	3.24	2.36	2.36	0.00	0.59	0.00	2.36	0.00	0.00
amygdala - adult, donor10196	10167-103B5	46.25	8.30	1.19	1.19	3.56	0.00	2.37	1.19	0.00	0.00
amygdala, adult, donor10252	10151-102I7	184.32	15.41	7.10	2.43	3.65	1.42	1.62	2.64	0.20	0.61
amygdala, newborn, donor10223	10360-105E9	32.92	3.55	0.97	0.00	1.61	0.00	0.32	0.00	0.32	0.65
anaplastic carcinoma cell line:8305C	10428-106D5	23.43	0.38	1.27	0.89	0.13	0.38	0.00	0.38	0.00	0.00
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	31.11	0.66	0.66	0.22	0.88	0.00	0.00	0.00	0.00	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	154.33	8.02	6.01	4.68	2.67	3.01	0.00	5.34	2.00	0.00
aorta, adult, pool1	10052-101G7	77.86	3.73	1.18	2.75	1.18	0.00	0.20	1.37	0.98	0.20
appendix, adult	10189-103D9	37.65	2.33	2.33	0.00	0.39	0.39	0.00	0.39	0.78	1.94
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	14.10	0.34	1.03	0.34	0.34	0.00	4.82	0.69	1.38	5.50
artery, adult	10190-103E1	65.22	5.43	1.36	0.00	1.36	0.00	2.72	1.36	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	35.64	1.45	2.32	1.30	1.30	2.90	0.00	0.87	0.29	0.00
b cell line:RPMI1788	10427-106D4	16.06	0.89	1.19	0.30	0.15	0.00	0.00	0.59	0.30	0.00
basal cell carcinoma cell line:TE 354.T	10702-109G9	169.80	15.54	2.22	0.83	2.50	1.39	0.00	0.83	0.28	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	43.76	2.08	1.29	0.79	0.50	0.69	0.00	0.89	0.30	0.00
bile duct carcinoma cell line:TFK-1	10496-107C1	35.48	3.18	1.67	1.34	0.50	0.84	0.00	1.51	0.17	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	10.07	0.00	0.00	0.00	0.56	0.56	0.00	0.00	0.00	0.00
bladder, adult, pool1	10011-101C2	54.10	3.04	1.74	1.30	0.33	0.43	0.87	1.09	0.43	0.43
blood, adult, pool1	10053-101G8	11.07	2.21	0.00	0.00	0.00	0.00	8.86	0.00	0.00	6.64
bone marrow stromal cell line:StromaNKtert	10686-109F2	52.24	5.14	0.00	0.86	0.00	0.86	0.00	0.86	0.00	0.00
bone marrow, adult	10192-103E3	42.51	5.40	1.35	3.37	0.67	0.67	0.67	0.00	0.00	0.67
brain, adult, donor1	10084-102B3	134.28	15.38	1.03	3.08	9.23	1.03	1.03	3.08	10.25	0.00
brain, adult, pool1	10012-101C3	80.85	6.79	2.00	2.34	3.34	0.78	2.78	1.00	0.67	1.11
brain, fetal, pool1	10085-102B4	85.48	10.69	0.00	0.00	2.67	8.01	0.00	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	43.94	10.24	1.32	0.99	0.66	0.00	0.00	0.66	0.00	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	52.05	3.12	0.62	0.50	0.62	0.62	0.00	0.75	0.00	0.00
breast, adult, donor1	10080-102A8	164.15	4.42	4.42	4.42	0.00	0.00	0.00	1.26	1.26	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	148.76	14.10	2.79	1.02	2.16	0.13	0.00	0.76	0.13	0.00
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	23.19	2.16	0.31	0.00	1.86	0.62	0.00	1.24	0.31	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	487.14	32.92	6.45	4.37	2.99	4.60	0.00	4.37	4.14	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	37.28	5.81	1.45	0.24	0.73	0.00	0.00	1.21	0.24	0.00
carcinoid cell line:NCI-H1770	10703-109H1	57.36	1.41	2.82	2.82	0.00	1.41	3.29	0.47	0.47	0.47
carcinoid cell line:NCI-H727	10735-110B6	20.34	2.63	1.09	0.55	0.44	0.77	0.00	1.09	0.00	0.00
carcinoid cell line:SK-PN-DW	10719-109I8	30.42	2.85	0.63	0.00	0.32	0.32	0.00	0.00	0.32	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	56.96	5.06	0.00	0.80	1.06	3.19	6.39	0.00	0.53	1.33
caudate nucleus - adult, donor10196	10177-103C6	148.52	8.06	3.45	3.45	6.91	0.00	3.45	4.61	1.15	0.00
caudate nucleus, adult, donor10252	10164-103B2	121.81	7.86	4.02	3.68	1.67	0.17	1.34	0.50	0.33	1.00
caudate nucleus, adult, donor10258	10379-105H1	81.76	9.17	1.53	0.76	0.76	0.00	2.29	0.76	0.76	0.76
caudate nucleus, newborn, donor10223	10354-105E3	80.57	9.52	1.10	1.83	2.56	0.37	1.83	0.00	0.37	1.10
cerebellum - adult, donor10196	10173-103C2	87.40	2.91	5.83	0.00	0.00	0.00	2.91	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	144.97	7.90	9.61	6.41	1.28	0.85	0.85	5.34	0.85	0.21
cerebellum, adult, pool1	10083-102B2	65.19	7.24	3.45	2.76	1.03	0.34	0.69	1.72	0.34	0.34
cerebellum, newborn, donor10223	10357-105E6	46.50	4.98	1.66	0.00	1.66	0.83	1.66	0.00	0.83	0.83
cerebral meninges, adult	10188-103D8	69.59	13.62	2.02	2.02	4.54	0.25	2.52	1.51	1.01	0.76
cerebrospinal fluid, donor2	10294-104G6	54.82	2.92	1.46	0.73	0.73	0.73	0.00	1.46	2.19	0.73
cervical cancer cell line:D98-AH2	10552-107I3	55.64	1.73	1.15	0.43	0.72	0.86	0.00	0.86	0.72	0.00
cervical cancer cell line:ME-180	10553-107I4	44.74	2.98	1.82	0.50	0.50	0.99	0.00	0.66	0.00	0.00
cervix, adult, pool1	10013-101C4	90.61	4.41	3.04	2.41	0.94	0.52	0.42	1.36	3.25	0.42
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	42.92	1.81	2.37	1.11	0.14	1.67	0.00	0.56	0.00	0.00
chondrosarcoma cell line:SW 1353	10700-109G7	24.82	2.61	1.31	1.31	0.00	0.00	0.00	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	26.97	0.50	6.71	1.74	0.62	0.25	0.00	5.34	1.62	0.00
choriocarcinoma cell line:SCH	10785-110H2	28.22	2.71	0.74	0.62	0.25	0.12	0.00	0.49	0.12	0.00
choriocarcinoma cell line:T3M-3	10618-108G6	8.78	0.47	0.47	0.47	0.00	0.00	0.00	0.47	0.47	0.00
chorionic membrane cells, donor1	12238-129G6	32.48	1.71	1.42	1.71	0.57	0.00	0.28	0.85	0.00	0.00
chorionic membrane cells, donor2	12239-129G7	235.45	14.42	6.26	5.27	2.29	1.09	0.00	2.68	4.87	0.00
chorionic membrane cells, donor3	12240-129G8	25.83	1.65	1.65	1.65	0.00	0.00	0.00	0.00	0.00	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	20.20	4.04	0.00	0.00	0.00	3.03	0.00	0.00	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	97.59	11.53	1.15	2.31	2.31	0.58	5.96	1.54	0.19	5.76
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	29.35	3.38	0.00	0.00	0.84	0.21	3.80	0.00	0.42	4.22
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	24.14	1.54	0.26	0.26	0.51	0.00	0.00	0.77	0.26	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	29.27	3.63	1.94	0.00	0.24	0.00	0.00	0.24	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	22.80	1.02	1.02	0.20	0.41	0.20	0.00	0.81	0.20	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	38.28	2.06	0.88	0.00	0.59	0.00	0.00	0.00	0.00	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	51.60	6.78	0.78	0.52	2.09	0.26	9.90	0.78	0.52	8.34
clear cell carcinoma cell line:JHOC-5	10638-108I8	32.23	1.37	1.37	0.46	0.23	0.00	0.00	0.46	0.23	0.00
clear cell carcinoma cell line:TEN	10636-108I6	37.82	2.43	0.69	0.35	0.87	0.35	0.00	0.17	0.00	0.00
colon carcinoma cell line:CACO-2	10513-107D9	57.66	4.76	3.29	1.28	1.46	0.55	0.00	0.92	0.92	0.00
colon carcinoma cell line:COLO-320	10420-106C6	57.39	1.14	1.52	2.66	1.14	0.76	0.00	1.90	0.38	0.00
colon, adult, donor1	10082-102B1	90.44	1.19	0.00	0.00	0.00	0.00	0.00	2.38	4.76	0.00
colon, adult, pool1	10014-101C5	52.99	1.76	2.59	3.88	0.12	0.12	0.00	1.41	4.00	0.12
colon, fetal, donor1	10070-101I7	45.73	5.56	0.00	1.24	1.24	0.00	0.00	0.62	0.62	0.00
common myeloid progenitor CMP, donor1	12130-128D6	64.17	9.17	9.17	0.00	4.58	0.00	0.00	0.00	0.00	4.58
common myeloid progenitor CMP, donor2	12134-128E1	175.26	0.00	0.00	25.04	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	34.84	1.27	0.85	1.70	0.85	0.85	0.00	0.42	0.00	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	81.05	4.68	3.77	1.66	0.75	0.60	0.00	1.66	7.70	0.00
cord blood derived cell line:COBL-a untreated	10449-106F8	73.75	5.08	2.82	0.85	1.55	1.13	0.00	1.27	0.28	0.00
corpus callosum, adult, pool1	10042-101F6	266.79	15.92	5.75	3.98	7.96	1.99	7.74	2.21	5.64	2.32
cruciate ligament, donor2	10295-104G7	29.99	0.81	0.81	0.00	0.00	0.00	0.00	0.00	0.00	0.81
diaphragm, fetal, donor1	10069-101I6	69.02	7.22	0.80	2.41	0.80	0.80	1.61	0.80	0.00	0.00
diencephalon, adult	10193-103E4	95.52	11.76	2.88	1.44	5.04	0.72	5.28	0.72	0.24	0.96
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	33.06	2.07	0.92	0.23	0.92	0.92	0.00	0.46	0.46	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	48.72	3.85	0.51	0.26	1.03	3.08	0.00	1.28	0.26	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	60.66	3.13	0.48	0.72	0.72	0.72	0.00	0.72	0.24	0.00
ductus deferens, adult	10196-103E7	50.33	1.99	3.99	1.99	1.00	0.00	0.00	1.50	0.00	0.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	67.69	11.52	1.44	2.88	0.00	1.44	0.00	0.00	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	47.82	5.89	2.21	0.74	0.74	2.21	0.74	0.00	0.74	0.74
dura mater, adult, donor1	10041-101F5	74.99	3.72	1.57	1.73	0.83	0.83	2.15	0.83	0.74	1.57
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	35.75	5.33	4.66	2.66	3.78	2.00	0.00	3.11	2.89	0.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	65.63	4.01	6.30	2.72	1.00	3.30	0.00	5.16	1.29	0.00
embryonic pancreas cell line:1B2C6	10604-108F1	37.61	1.23	0.62	0.62	0.00	0.00	0.00	0.00	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	42.68	1.21	0.61	0.61	0.00	0.00	0.00	0.30	0.61	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	44.77	0.93	0.93	0.31	0.00	0.00	0.00	0.00	0.93	0.00
embryonic pancreas cell line:2C6	10603-108E9	34.15	3.94	3.94	1.31	0.00	0.00	0.00	2.63	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	47.26	3.69	3.02	0.67	1.34	0.67	0.00	1.68	0.00	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	133.21	7.79	3.62	1.09	1.09	0.91	0.00	1.81	0.54	0.00
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	65.13	4.50	1.29	1.93	0.48	1.29	0.00	0.96	0.32	0.00
epidermoid carcinoma cell line:A431	10426-106D3	34.13	3.89	0.44	0.89	0.78	0.11	0.00	0.11	0.44	0.00
epidermoid carcinoma cell line:Ca Ski	10431-106D8	71.60	4.07	1.43	0.66	0.99	1.10	0.00	1.43	0.22	0.00
epididymis, adult	10197-103E8	55.47	2.93	2.51	1.88	0.00	0.63	0.63	1.47	1.26	0.63
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	58.72	1.60	1.77	0.53	0.00	0.35	0.00	0.71	0.18	0.00
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	58.20	4.72	3.93	1.57	0.00	0.39	0.00	2.36	0.39	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	82.82	10.35	2.36	0.66	1.05	3.41	0.00	1.18	0.13	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	76.18	8.37	3.54	1.87	0.69	3.35	0.00	1.57	0.20	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	94.33	11.09	2.35	1.90	1.57	3.47	0.00	2.13	0.11	0.00
esophagus, adult, pool1	10015-101C6	67.74	6.16	3.19	1.38	0.53	0.85	0.00	1.38	1.81	0.32
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	88.17	6.01	4.26	3.76	1.88	2.63	0.00	3.63	2.13	0.00
eye - muscle inferior rectus, donor1	10272-104E2	28.97	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	27.35	2.10	0.00	0.00	0.00	0.00	2.10	0.00	0.00	2.10
eye - muscle medial, donor2	10299-104H2	22.32	0.00	0.00	1.49	4.46	0.00	0.00	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	55.03	2.29	1.15	3.44	0.00	0.00	0.00	1.15	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	27.69	5.83	1.46	0.00	1.46	0.00	0.00	1.46	0.00	0.00
eye, fetal, donor1	10054-101G9	65.34	4.07	1.53	1.53	0.51	0.25	2.80	0.76	0.00	0.76
fibrosarcoma cell line:HT-1080	10758-110E2	29.49	3.21	1.15	0.26	1.15	0.00	0.00	0.26	0.26	0.00
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	69.09	4.27	0.95	0.47	0.71	0.71	0.00	1.19	0.00	0.00
frontal lobe, adult, pool1	10040-101F4	91.76	6.66	3.57	3.19	4.60	0.94	3.75	2.35	1.78	1.22
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	54.95	5.40	1.80	0.30	0.60	0.60	0.00	1.80	0.60	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	33.56	0.64	0.82	0.64	0.09	0.27	0.00	0.37	0.09	0.00
gall bladder, adult	10198-103E9	69.77	5.07	2.17	0.97	0.00	1.21	0.00	1.45	2.41	0.24
gamma delta positive T cells, donor1	11937-126A2	17.72	0.54	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
gamma delta positive T cells, donor2	11938-126A3	27.26	2.99	0.00	0.00	0.75	0.00	2.61	1.49	0.75	3.36
gastric adenocarcinoma cell line:MKN1	10614-108G2	86.18	10.14	2.96	2.32	1.06	0.42	0.00	0.63	0.63	0.00
gastric adenocarcinoma cell line:MKN45	10612-108F9	53.38	3.09	1.74	0.58	0.39	1.74	0.00	1.16	0.19	0.00
gastric cancer cell line:AZ521	10549-107H9	102.80	7.87	4.43	2.62	0.66	0.66	0.00	3.61	0.16	0.00
gastric cancer cell line:GSS	10560-108A2	35.69	0.92	1.83	0.00	0.00	0.00	0.00	0.00	1.83	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	25.82	1.60	0.69	0.69	1.14	1.14	0.23	0.00	0.69	0.00
giant cell carcinoma cell line:LU65	10487-107B1	18.59	0.46	0.92	0.34	0.00	0.11	0.00	0.23	0.00	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	83.14	2.80	2.94	2.10	0.42	1.12	0.00	1.26	0.56	0.00
glassy cell carcinoma cell line:HOKUG	10688-109F4	60.61	6.98	1.25	1.75	0.75	1.25	0.00	1.00	0.75	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	62.80	3.06	2.01	0.84	0.32	0.21	0.00	0.74	0.11	0.00
glioblastoma cell line:A172, tech_rep2	10444-106F3	67.55	2.81	0.84	0.98	0.14	0.00	0.00	0.28	0.14	0.00
glioblastoma cell line:T98G	10485-107A8	76.60	3.09	1.10	0.33	0.11	1.21	0.00	0.44	0.00	0.00
glioma cell line:GI-1	10413-106B8	98.41	8.49	3.22	0.59	0.88	0.59	0.00	2.34	2.05	0.00
globus pallidus - adult, donor10196	10175-103C4	137.04	18.95	0.73	2.19	1.46	0.00	3.64	0.73	0.00	0.73
globus pallidus, adult, donor10252	10161-103A8	283.64	20.26	11.47	9.52	4.15	0.49	3.17	5.37	1.71	1.22
globus pallidus, adult, donor10258	10367-105F7	146.51	17.80	1.37	2.74	4.11	0.00	5.48	0.00	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	111.38	12.79	1.07	1.60	2.66	0.00	4.80	2.13	1.07	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	53.84	7.34	4.89	2.45	2.45	0.00	4.89	0.00	0.00	4.89
granulocyte macrophage progenitor, donor2	12135-128E2	32.79	10.93	0.00	10.93	0.00	0.00	0.00	0.00	0.00	21.86
granulocyte macrophage progenitor, donor3	12139-128E6	73.17	0.00	0.00	0.00	5.23	5.23	10.45	0.00	0.00	26.13
granulosa cell tumor cell line:KGN	10624-108H3	73.92	11.20	1.92	1.28	0.32	0.32	0.00	0.32	0.32	0.00
hIPS +CCl2, biol_rep1	14383-156B9	64.28	9.64	2.30	2.30	3.21	0.46	0.00	1.38	0.92	0.00
hIPS +CCl2, biol_rep2	14384-156C1	53.96	8.23	0.91	1.37	3.66	0.00	0.00	2.74	0.00	0.00
hIPS +CCl2, biol_rep3	14385-156C2	66.34	5.15	1.93	1.29	3.86	0.00	0.00	0.64	0.00	0.00
hIPS, biol_rep1	14380-156B6	30.18	7.19	4.31	1.44	2.87	0.00	0.00	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	59.67	6.86	2.06	0.69	2.06	0.00	0.00	0.69	0.00	0.00
hIPS, biol_rep3	14382-156B8	69.52	17.66	0.00	0.00	7.72	0.00	2.21	2.21	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	21.84	3.16	0.57	0.86	1.44	0.29	0.00	0.86	0.00	0.00
heart - mitral valve, adult	10205-103F7	53.52	6.58	1.79	0.90	0.30	0.60	0.00	0.00	0.30	0.00
heart - pulmonic valve, adult	10206-103F8	40.53	1.83	1.83	0.78	1.05	0.26	0.78	0.26	0.26	0.26
heart - tricuspid valve, adult	10207-103F9	50.79	1.67	2.50	0.83	0.00	0.00	0.83	0.00	0.00	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	57.95	5.71	1.43	0.61	0.41	0.41	0.00	1.02	0.61	0.00
heart, adult, diseased, donor1	10051-101G6	64.30	3.41	0.85	0.43	0.00	0.00	0.00	0.43	2.13	0.00
heart, adult, pool1	10016-101C7	61.63	2.53	2.99	2.99	0.69	0.00	0.00	1.84	1.15	0.23
heart, fetal, pool1	10046-101G1	76.50	3.08	2.98	1.85	0.82	1.13	0.62	2.05	0.51	0.41
hepatic mesenchymal tumor cell line:LI90	10778-110G4	174.93	7.71	2.47	2.16	1.54	0.31	0.00	0.62	0.00	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	21.41	1.19	0.00	0.00	0.00	0.00	0.00	0.00	1.19	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	94.03	13.15	11.60	9.50	1.33	0.99	0.00	3.54	0.44	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	103.41	12.38	11.29	8.37	1.70	1.09	0.00	4.49	0.12	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	106.91	13.24	13.14	10.00	2.12	0.81	0.00	5.86	0.10	0.00
hepatoma cell line:Li-7	10484-107A7	80.41	2.56	5.23	3.11	1.11	4.67	0.00	1.11	0.44	0.00
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	39.50	2.41	1.31	1.01	1.61	0.90	0.00	0.40	0.20	0.00
hippocampus - adult, donor10196	10169-103B7	74.76	8.52	0.95	0.00	0.95	1.89	2.84	0.00	0.00	0.95
hippocampus, adult, donor10252	10153-102I9	270.02	20.61	12.65	7.35	3.47	0.61	1.43	2.86	0.82	0.41
hippocampus, adult, donor10258	10374-105G5	32.37	5.98	1.00	0.50	0.50	1.49	1.49	0.00	0.00	1.99
hippocampus, newborn, donor10223	10363-105F3	51.11	5.64	1.41	0.70	3.17	0.00	0.35	0.00	0.70	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	86.06	8.54	2.44	3.66	2.44	1.22	0.00	1.83	0.61	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	116.24	13.55	3.53	3.73	3.93	0.79	0.00	2.95	2.16	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	99.27	12.44	5.08	2.54	3.55	0.00	0.00	1.52	1.27	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	104.31	5.07	1.13	2.82	1.69	0.00	0.00	2.82	9.02	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	153.64	5.16	2.32	1.29	2.58	0.00	0.00	1.81	14.20	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	94.14	2.66	2.66	2.66	0.76	0.00	0.00	0.38	10.25	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	52.26	4.38	1.46	1.17	0.58	1.17	0.00	0.58	4.96	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	78.63	2.80	1.72	1.94	1.08	1.72	0.00	0.65	6.46	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	79.66	2.09	2.09	1.25	1.25	2.09	0.00	0.83	4.59	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	94.95	5.21	1.18	2.37	3.79	11.60	0.00	0.47	4.50	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	99.16	6.75	3.21	1.61	3.21	8.52	0.00	0.64	5.30	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	91.57	6.73	2.69	2.02	2.69	12.12	0.00	1.35	4.71	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	129.41	13.14	3.60	4.69	5.79	1.25	0.00	2.97	2.35	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	95.80	17.69	3.44	2.95	5.40	0.00	0.00	4.91	0.98	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	74.18	8.73	3.49	0.87	4.36	0.87	0.00	1.75	1.75	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	151.77	2.48	2.67	2.67	0.95	0.38	0.00	0.76	12.22	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	129.95	4.36	0.87	1.31	1.74	0.00	0.00	0.44	8.29	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	73.96	5.00	2.00	0.50	0.00	0.50	0.00	1.50	4.50	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	38.62	0.57	1.70	0.75	0.19	0.38	0.00	0.38	5.09	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	43.65	2.27	1.36	1.82	0.00	0.45	0.00	0.00	3.64	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	33.20	0.94	1.25	0.31	0.63	0.31	0.00	0.94	5.64	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	78.55	4.74	2.45	2.94	1.96	7.51	0.00	1.31	6.37	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	62.42	3.19	1.16	1.45	1.74	4.94	0.00	0.58	5.23	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	57.99	3.89	2.39	2.69	0.90	5.68	0.00	2.69	6.58	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	145.02	12.38	5.36	3.51	5.54	1.85	0.00	2.40	2.77	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	148.06	9.98	4.28	4.28	3.14	1.14	0.00	2.85	4.85	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	113.51	12.66	4.08	2.86	3.67	3.27	0.41	0.82	1.63	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	102.10	4.22	3.52	3.52	1.41	0.00	0.00	2.46	10.91	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	142.85	3.48	2.53	4.12	1.90	0.32	0.00	0.95	9.19	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	99.56	5.75	3.63	3.63	0.91	0.30	0.00	2.42	10.29	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	49.64	2.59	1.55	0.52	0.00	0.52	0.00	0.52	4.14	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	59.11	2.66	1.33	1.33	0.66	3.32	0.00	1.33	3.32	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	42.33	3.33	1.03	0.51	0.77	2.57	0.00	0.26	3.08	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	69.02	5.37	1.28	1.28	2.56	10.23	0.00	0.77	5.62	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	91.62	2.27	3.03	0.76	4.54	11.36	0.00	0.00	5.30	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	76.29	5.04	2.02	2.69	2.02	7.73	0.00	1.01	3.70	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	135.00	12.32	2.66	3.86	4.83	1.45	0.00	1.69	1.93	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	94.48	11.59	3.57	2.67	5.35	0.89	0.00	2.23	2.67	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	138.54	8.78	2.44	2.93	3.90	0.00	0.00	1.46	3.41	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	94.44	2.14	3.06	3.36	0.92	0.61	0.00	1.22	8.25	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	39.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00	13.01	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	58.91	1.65	0.99	1.65	0.33	0.33	0.00	0.66	7.61	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	44.88	1.64	1.09	2.19	1.09	2.74	0.00	0.55	1.64	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	41.62	0.72	1.45	1.09	0.72	1.81	0.00	0.72	2.90	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	29.54	2.49	0.71	2.14	0.00	0.71	0.00	0.71	3.56	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	66.83	8.35	0.00	1.19	1.19	8.35	0.00	0.00	3.58	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	57.56	5.01	3.66	1.49	2.98	12.46	0.00	0.54	5.15	0.14
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	62.77	4.04	1.35	1.89	2.42	7.00	0.00	0.81	2.16	0.00
immature langerhans cells, donor1	11904-125F5	14.77	4.60	1.94	1.45	0.97	0.73	0.00	2.18	0.00	0.00
immature langerhans cells, donor2	11905-125F6	16.63	6.34	6.34	0.79	0.00	2.38	0.00	2.38	0.00	0.00
insula, adult, pool1	10039-101F3	84.60	5.49	2.46	2.84	3.79	1.23	3.79	1.99	2.74	1.23
keratoacanthoma cell line:HKA-1	10791-110H8	56.90	8.78	0.00	0.65	0.98	0.33	0.00	0.33	0.33	0.00
kidney, adult, pool1	10017-101C8	65.58	2.90	4.21	3.20	0.50	0.90	0.10	2.30	0.80	0.20
kidney, fetal, pool1	10045-101F9	61.12	2.76	4.03	3.47	0.71	0.50	0.57	2.12	0.92	0.42
large cell lung carcinoma cell line:IA-LM	10509-107D5	39.06	2.70	0.99	0.28	1.42	1.14	0.00	1.28	0.85	0.00
large cell lung carcinoma cell line:NCI-H460	10839-111E2	34.56	1.38	0.97	0.41	0.28	0.28	0.00	0.28	0.14	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	23.12	2.02	0.18	0.55	0.92	0.00	0.00	0.55	0.18	0.00
left atrium, adult, donor1	10079-102A7	70.83	5.45	2.18	1.63	0.00	0.54	0.00	0.00	1.09	0.54
left ventricle, adult, donor1	10078-102A6	61.18	3.54	2.53	0.51	0.51	0.00	1.01	0.00	0.00	0.51
leiomyoblastoma cell line:G-402	10721-110A1	179.21	13.95	1.92	2.19	1.92	1.09	0.00	0.82	0.55	0.00
leiomyoma cell line:10964C	10569-108B2	147.29	12.57	1.44	0.36	2.16	3.23	0.00	0.36	1.44	0.00
leiomyoma cell line:15242A	10570-108B3	168.48	21.20	1.63	1.09	2.72	0.54	0.00	1.09	2.72	0.00
leiomyoma cell line:15425	10571-108B4	151.52	15.30	1.46	1.21	4.37	1.70	0.00	0.24	2.43	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	133.34	0.00	6.35	25.40	0.00	6.35	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	71.10	3.14	1.05	0.00	0.00	1.05	0.00	1.05	2.09	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	37.78	2.95	0.47	1.18	1.65	0.24	0.12	0.47	0.59	0.12
liposarcoma cell line:KMLS-1	10782-110G8	201.67	16.40	2.50	2.34	1.87	2.34	0.00	0.94	0.62	0.00
liposarcoma cell line:SW 872	10726-110A6	109.78	10.84	5.12	3.41	1.58	0.97	0.00	3.05	0.61	0.00
liver, adult, pool1	10018-101C9	46.51	3.40	1.62	0.97	0.49	0.16	0.16	0.49	0.49	0.16
liver, fetal, pool1	10086-102B5	45.15	2.82	0.00	1.88	0.00	0.00	0.94	0.94	5.64	0.00
locus coeruleus - adult, donor10196	10182-103D2	143.05	18.67	2.48	3.06	5.25	1.31	3.35	0.87	0.58	0.29
locus coeruleus, adult, donor10252	10165-103B3	178.46	12.73	10.89	6.27	3.88	0.74	1.85	2.77	0.55	0.37
locus coeruleus, adult, donor10258	10375-105G6	167.59	25.96	3.95	3.95	6.49	1.13	3.39	0.56	0.00	0.00
locus coeruleus, newborn, donor10223	10362-105F2	65.62	10.94	1.26	0.84	0.00	0.00	2.10	0.42	0.84	1.68
lung adenocarcinoma cell line:A549	10499-107C4	31.97	2.49	1.25	0.83	0.28	1.66	0.00	0.55	0.14	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	15.86	0.69	0.69	0.00	0.00	0.00	0.00	0.00	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	30.84	4.61	1.58	1.05	0.92	1.05	0.00	1.45	0.00	0.00
lung, adult, pool1	10019-101D1	53.98	1.42	3.54	3.07	0.12	0.35	0.47	0.95	1.42	0.35
lung, fetal, donor1	10068-101I5	42.53	2.57	3.14	2.00	0.29	1.71	4.57	0.86	0.57	2.28
lung, right lower lobe, adult, donor1	10075-102A3	82.02	5.50	1.37	2.29	0.46	0.46	0.92	1.83	2.75	0.92
lymph node, adult, donor1	10077-102A5	57.75	1.89	2.84	0.95	0.47	0.00	0.00	1.42	0.00	2.37
lymphangiectasia cell line:DS-1	10727-110A7	10.74	0.66	0.66	0.22	0.22	0.00	0.00	0.00	0.22	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	27.17	3.62	0.15	0.15	1.96	0.45	0.00	0.30	0.00	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	40.78	4.25	0.00	0.85	1.70	3.40	0.00	0.00	0.85	0.00
mature adipocyte, donor1	12231-129F8	47.51	1.78	0.89	0.44	0.44	0.00	0.00	0.00	0.00	0.44
mature adipocyte, donor2	12232-129F9	71.18	2.49	1.04	1.04	0.21	0.21	0.42	0.00	0.42	0.00
mature adipocyte, donor3	12233-129G1	50.73	1.19	0.71	1.19	0.47	0.24	0.00	0.47	0.24	0.00
mature adipocyte, donor4	12234-129G2	37.11	3.16	0.53	0.26	0.00	0.26	0.00	0.26	0.00	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	55.99	1.67	3.34	1.91	0.00	2.38	0.00	1.19	0.95	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	48.51	3.38	2.26	1.13	2.26	0.00	3.38	2.26	1.13	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	136.83	11.59	5.70	6.07	3.13	0.18	0.92	1.47	0.37	0.92
medial frontal gyrus, adult, donor10258	10368-105F8	37.80	7.62	1.59	1.27	1.27	0.00	0.95	1.27	0.00	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	23.46	6.40	0.43	0.43	4.26	5.12	1.28	0.43	0.43	0.85
medial temporal gyrus - adult, donor10196	10183-103D3	58.73	10.80	2.03	1.69	2.19	1.18	2.36	1.18	0.68	0.34
medial temporal gyrus, adult, donor10252	10156-103A3	147.50	9.55	7.43	4.03	1.91	0.85	1.91	3.18	0.85	0.85
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	15.41	5.78	0.00	0.00	0.00	0.00	1.93	0.00	0.00	1.93
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	36.25	4.67	1.79	1.08	1.79	1.79	1.44	0.36	0.00	0.00
medulla oblongata - adult, donor10196	10174-103C3	125.90	11.03	1.95	1.95	3.89	0.65	2.60	0.65	0.65	0.65
medulla oblongata, adult, donor10252	10155-103A2	251.09	16.25	12.54	8.51	4.95	1.08	2.94	4.64	0.62	0.77
medulla oblongata, adult, pool1	10038-101F2	182.44	12.16	6.29	4.73	5.71	1.14	5.88	2.86	2.45	1.71
medulla oblongata, newborn, donor10223	10361-105F1	133.66	15.28	3.82	1.74	2.43	1.39	1.39	1.39	0.69	1.74
medulloblastoma cell line:D283 Med	10838-111E1	24.36	3.99	0.44	0.22	2.44	1.33	0.44	1.33	0.22	0.00
medulloblastoma cell line:ONS-76	10759-110E3	106.26	9.90	2.45	2.08	3.18	0.37	0.00	1.35	0.61	0.00
melanoma cell line:COLO 679	10514-107E1	63.10	4.46	1.87	0.86	0.72	2.59	0.00	0.72	1.58	0.00
melanoma cell line:G-361	10465-106H6	139.26	7.87	1.63	3.26	4.07	1.63	0.00	0.54	4.34	0.00
meningioma cell line:HKBMM	10691-109F7	43.96	1.99	0.90	0.54	0.54	0.36	0.00	0.90	0.36	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	225.58	16.74	0.88	0.88	2.64	9.69	9.69	1.76	0.88	1.76
merkel cell carcinoma cell line:MS-1	10844-111E7	233.04	23.59	2.85	3.11	9.59	19.44	43.55	4.15	1.81	7.52
mesenchymal precursor cell - adipose, donor1	11747-123G1	172.61	18.41	1.53	0.92	1.69	2.15	0.00	0.61	1.23	0.00
mesenchymal precursor cell - adipose, donor2	11748-123G2	143.79	14.00	1.64	1.09	0.91	0.36	0.00	0.73	0.91	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	103.94	16.15	0.83	0.41	1.66	0.41	0.00	0.00	0.41	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	142.16	12.64	2.81	2.11	0.98	0.84	0.00	0.70	0.56	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	130.37	5.97	2.31	2.12	0.58	0.77	0.00	0.96	0.77	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	138.12	11.80	0.69	2.78	2.78	0.69	0.69	2.78	1.39	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	78.09	6.69	0.69	1.72	0.00	1.03	0.00	0.34	0.86	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	106.39	9.66	1.15	1.61	0.81	1.04	0.00	0.81	1.50	0.00
mesenchymal precursor cell - cardiac, donor3	11754-123G8	189.14	17.51	1.46	1.33	1.46	0.53	0.00	1.86	0.66	0.00
mesenchymal precursor cell - cardiac, donor4	11755-123G9	163.53	15.26	3.11	2.70	1.76	2.03	0.00	0.68	1.08	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	149.52	14.65	2.56	2.28	1.99	1.14	0.00	1.71	0.71	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	45.45	1.98	0.99	1.98	0.33	0.33	0.00	0.33	0.66	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	105.16	10.24	2.63	1.52	2.21	1.66	0.00	1.52	0.14	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	176.99	13.96	0.70	1.40	2.09	1.05	0.00	0.35	1.75	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	162.31	14.90	2.25	2.45	0.61	1.02	0.00	1.02	0.20	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	121.14	10.42	0.36	1.44	0.36	0.72	0.00	1.08	1.44	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	111.11	9.00	3.10	1.55	0.31	0.52	0.00	1.55	0.62	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	121.29	9.80	4.10	1.14	2.51	0.46	0.00	0.68	0.46	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	100.69	15.94	1.26	1.68	2.10	2.52	0.00	0.84	0.42	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	124.78	10.01	2.39	1.79	0.60	0.90	0.00	0.45	1.05	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	129.81	8.23	3.15	1.93	1.05	0.53	0.00	2.01	0.79	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	114.87	8.10	4.05	2.21	1.10	0.00	0.00	0.37	0.37	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	136.21	13.45	2.58	2.29	1.72	0.57	0.00	1.14	1.14	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	224.40	24.42	2.11	2.11	4.63	7.16	5.89	1.26	2.53	1.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	192.26	19.64	1.83	0.91	6.85	1.37	0.00	0.46	2.74	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	177.51	19.95	1.02	1.28	3.84	1.02	0.00	0.51	1.02	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	220.14	23.03	1.83	1.31	6.54	1.57	0.00	1.31	1.05	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	200.56	24.03	1.54	0.31	4.62	1.54	0.00	1.54	2.46	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	166.87	26.12	1.65	2.59	5.41	1.41	0.00	1.41	1.41	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	208.15	24.71	1.69	1.35	4.40	3.72	0.00	1.35	1.35	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	228.71	19.65	1.18	3.14	7.07	1.18	0.00	0.39	0.39	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	174.70	23.17	0.46	0.46	4.17	0.93	0.00	0.93	0.93	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	144.91	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	209.68	26.82	1.73	1.15	6.92	3.46	0.00	0.29	0.87	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	201.24	20.30	2.23	2.01	4.69	2.45	0.00	0.89	2.23	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	206.46	25.48	1.68	1.20	5.05	2.40	0.00	1.20	1.20	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	167.93	25.67	0.73	0.73	3.67	0.00	0.00	0.00	1.47	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	180.92	21.82	1.68	1.68	3.36	1.34	0.00	0.67	2.69	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	179.72	18.83	2.46	0.82	2.46	2.87	0.00	0.82	2.05	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	183.85	21.05	1.29	1.29	5.15	2.15	0.00	1.29	1.29	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	175.00	30.08	0.00	0.00	0.00	2.73	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	165.28	10.33	5.16	0.00	0.00	0.00	0.00	0.00	5.16	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	161.09	19.49	0.32	0.65	3.90	0.65	0.00	0.97	2.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	216.79	26.19	1.45	1.45	4.36	2.91	0.00	1.45	2.91	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	270.27	29.32	2.13	1.07	4.26	1.07	0.00	0.53	3.20	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	211.80	34.35	3.27	0.82	2.45	2.45	0.00	0.82	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	212.63	28.38	1.94	0.78	5.44	1.94	0.00	0.39	2.72	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	182.59	20.99	2.10	0.00	8.39	2.10	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	177.83	21.86	0.00	0.00	4.97	0.99	0.00	0.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	209.76	19.07	4.77	4.77	0.00	4.77	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	215.25	20.16	1.78	1.78	5.34	1.78	0.00	2.96	2.37	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	183.99	29.24	1.22	0.00	3.66	1.22	0.00	0.00	3.66	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	216.42	27.05	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	232.45	36.74	0.63	0.63	6.33	0.63	0.00	1.27	2.53	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	162.10	17.59	0.69	0.69	3.45	0.69	0.00	0.00	1.38	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	195.58	10.75	2.15	0.00	2.15	0.00	0.00	0.00	2.15	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	95.80	7.98	0.00	0.00	3.99	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	120.54	3.44	3.44	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	127.95	11.82	0.81	0.81	0.41	1.22	0.00	0.41	2.44	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	138.23	15.89	0.00	2.38	0.79	0.00	0.00	0.79	0.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	130.29	11.79	0.00	0.00	0.00	0.00	0.00	0.59	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	127.18	8.42	0.00	0.62	2.49	0.31	0.00	0.62	0.31	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	118.96	9.36	1.34	2.67	1.34	0.00	0.00	0.00	4.01	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	106.44	10.64	1.18	1.18	2.37	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	112.99	12.84	0.00	2.57	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	131.48	10.33	0.69	1.38	0.69	1.38	0.00	0.00	1.38	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	91.54	4.45	0.99	0.49	0.99	0.00	0.00	0.49	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	75.14	10.09	1.12	1.12	2.24	1.12	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	90.32	12.09	1.91	0.64	0.64	0.00	0.00	0.00	1.91	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	77.78	5.64	0.40	0.40	0.40	1.61	0.00	0.40	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	67.60	6.54	0.00	0.00	0.00	4.36	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	73.49	2.53	0.00	1.27	1.27	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	50.98	5.46	0.61	0.00	0.00	0.61	0.00	1.21	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	31.63	13.56	9.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	62.60	4.12	0.82	0.82	0.00	1.65	0.00	0.82	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	152.39	10.32	0.99	0.40	0.40	1.39	0.00	0.79	0.79	0.20
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	140.18	15.58	0.32	0.32	0.65	0.65	0.00	0.00	0.65	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	157.89	8.15	0.00	2.04	0.00	0.00	0.00	0.00	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	39.46	0.77	0.00	0.77	0.00	0.77	0.00	0.00	0.77	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	76.54	1.18	0.71	0.24	0.94	0.24	0.00	0.71	0.24	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	134.60	7.65	0.23	2.09	0.93	0.93	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	29.92	4.27	8.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	35.14	4.01	0.51	0.31	0.51	0.72	0.00	0.00	0.21	0.00
mesothelioma cell line:Mero-25	10850-111F4	62.19	3.86	4.09	1.59	0.91	1.82	0.00	0.91	0.00	0.00
mesothelioma cell line:Mero-41	10851-111F5	125.66	9.53	2.69	1.96	1.22	0.49	0.00	0.73	0.00	0.00
mesothelioma cell line:Mero-48a	10852-111F6	82.37	4.65	1.99	1.33	0.44	1.99	0.00	0.66	0.22	0.00
mesothelioma cell line:Mero-82	10853-111F7	100.13	6.31	3.15	1.84	1.05	0.26	0.00	1.05	0.79	0.00
mesothelioma cell line:Mero-83	10854-111F8	79.49	6.13	1.70	1.36	2.55	1.53	0.00	0.51	1.02	0.00
mesothelioma cell line:Mero-84	10855-111F9	127.90	11.88	2.53	2.02	3.79	0.76	0.00	0.76	0.51	0.00
mesothelioma cell line:Mero-95	10856-111G1	101.86	11.18	1.86	1.24	1.86	0.21	0.00	0.62	0.83	0.00
mesothelioma cell line:NCI-H2052	10847-111F1	79.68	7.29	2.48	0.50	0.66	1.16	0.00	0.83	0.00	0.00
mesothelioma cell line:NCI-H226	10846-111E9	122.89	17.01	2.53	2.53	2.35	1.45	0.00	1.27	0.18	0.00
mesothelioma cell line:NCI-H2452	10848-111F2	97.88	4.61	3.25	1.54	0.00	0.34	0.00	0.85	0.00	0.00
mesothelioma cell line:NCI-H28	10845-111E8	39.95	2.04	2.04	1.02	0.76	1.02	0.00	0.51	0.00	0.00
mesothelioma cell line:No36	10857-111G2	81.88	4.24	2.28	0.98	0.33	1.96	0.00	1.63	0.33	0.00
mesothelioma cell line:ONE58	10858-111G3	70.45	3.52	4.61	1.63	0.00	0.81	0.00	0.81	0.00	0.00
migratory langerhans cells, donor1	11901-125F2	66.02	14.01	0.58	0.00	0.58	0.19	0.00	0.38	0.00	0.00
migratory langerhans cells, donor2	11902-125F3	64.60	15.51	1.34	0.73	1.22	0.24	0.00	0.12	0.12	0.00
migratory langerhans cells, donor3	11903-125F4	59.23	7.18	0.72	0.18	0.18	0.18	0.00	1.26	0.00	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	62.36	2.29	4.24	1.31	0.33	0.00	0.00	1.96	0.00	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	77.99	11.23	2.97	1.70	3.60	1.27	0.00	2.12	0.00	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	67.73	7.60	2.07	2.53	1.15	0.23	0.00	0.46	0.23	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	42.63	2.85	0.76	1.33	0.57	0.00	0.00	0.95	0.19	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	26.98	2.03	0.74	0.37	0.55	0.55	0.00	0.18	0.00	0.00
myeloma cell line:PCM6	10474-106I6	16.21	1.19	0.00	0.40	0.00	0.20	0.00	0.00	0.00	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	32.47	11.16	0.00	0.00	0.51	0.51	0.00	0.00	0.51	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	52.76	4.71	0.59	0.98	1.18	0.39	0.00	0.59	0.20	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	44.24	1.67	1.56	0.56	0.33	0.45	0.00	0.56	0.00	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	37.65	2.43	0.74	0.29	0.44	0.37	0.00	0.22	0.07	0.00
nasal epithelial cells, donor2	12227-129F4	70.10	3.86	1.10	1.10	2.21	0.55	0.00	0.55	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	60.51	4.14	2.07	1.38	2.99	21.17	46.01	0.92	1.15	5.75
neuroblastoma cell line:NB-1	10539-107G8	199.99	5.43	5.43	1.68	3.93	6.55	2.06	1.50	0.37	0.37
neuroblastoma cell line:NBsusSR	10607-108F4	45.76	1.48	2.11	1.27	0.21	2.95	0.21	1.05	1.90	0.21
neuroblastoma cell line:NH-12	10555-107I6	97.46	4.66	2.42	2.42	1.86	7.64	11.18	1.12	0.93	2.24
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	12.10	0.47	0.24	0.00	0.24	0.00	0.00	0.00	0.00	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	41.81	0.95	0.79	0.95	0.63	2.06	0.48	0.00	1.58	0.00
neuroectodermal tumor cell line:TASK1	10774-110F9	35.42	1.61	0.60	0.40	1.21	0.20	0.20	0.00	0.00	0.20
neuroepithelioma cell line:SK-N-MC	10728-110A8	25.43	1.91	0.00	0.00	0.64	0.00	0.00	0.00	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	128.03	15.44	0.80	1.60	2.40	0.00	0.00	1.33	0.27	0.00
neutrophil PMN, donor1	12133-128D9	14.87	0.00	14.87	0.00	0.00	0.00	0.00	14.87	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	0.00	13.28	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	18.94	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	118.05	5.07	3.89	2.71	0.68	0.85	0.51	3.38	0.17	0.17
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	25.62	2.40	4.80	0.80	0.00	5.60	0.00	1.60	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	135.62	9.30	1.92	0.96	2.24	1.92	0.00	1.28	0.64	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	116.14	13.93	1.05	0.79	1.58	0.79	0.00	1.05	0.26	0.00
nucleus accumbens, adult, pool1	10037-101F1	96.93	5.72	3.19	2.53	3.09	0.66	3.19	1.50	1.41	0.56
occipital cortex - adult, donor10196	10172-103C1	53.57	14.42	0.00	0.00	2.06	0.00	0.00	0.00	2.06	0.00
occipital cortex, adult, donor10252	10163-103B1	203.15	16.10	12.61	11.54	2.42	0.54	1.07	4.56	0.27	0.00
occipital cortex, newborn, donor10223	10355-105E4	33.85	9.46	0.73	0.00	4.37	1.82	0.73	1.46	1.09	0.36
occipital lobe, adult, donor1	10076-102A4	181.84	10.50	2.10	1.05	3.15	0.52	1.05	1.05	5.77	0.79
occipital lobe, fetal, donor1	10073-102A1	104.70	12.01	1.29	0.43	7.72	15.02	9.87	0.43	0.43	0.00
occipital pole, adult, pool1	10036-101E9	88.07	8.36	5.28	3.47	3.71	0.63	2.68	2.52	1.81	0.47
olfactory region, adult	10195-103E6	99.73	7.64	2.10	0.76	3.06	1.15	1.91	0.19	0.57	0.76
optic nerve, donor1	10277-104E7	150.08	8.00	2.00	2.00	2.00	0.00	10.01	2.00	8.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	89.19	6.15	3.65	3.42	0.68	2.51	0.00	1.59	1.94	0.00
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	52.07	1.92	0.96	1.24	1.51	0.55	0.00	0.27	0.00	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	34.20	6.77	0.17	0.17	0.00	1.02	0.00	0.34	0.34	0.00
oral squamous cell carcinoma cell line:SAS	10544-107H4	75.77	6.35	2.08	2.08	1.16	0.46	0.00	1.27	0.69	0.00
osteoclastoma cell line:Hs 706.T	10704-109H2	115.53	8.23	3.53	2.65	1.47	2.06	0.00	1.47	4.12	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	17.75	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	80.58	9.33	1.70	1.06	1.70	5.30	0.00	2.33	0.21	0.00
ovary, adult, pool1	10020-101D2	53.20	1.57	3.49	1.14	0.09	0.52	0.17	1.05	0.61	0.17
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	28.60	4.22	1.10	0.18	0.37	0.00	0.00	1.10	0.00	0.00
pancreas, adult, donor1	10049-101G4	31.04	0.94	2.82	0.00	0.00	0.00	0.00	0.00	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	25.44	1.40	1.40	0.00	0.00	0.00	0.00	0.84	0.56	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	35.09	1.19	1.19	0.85	0.00	0.00	0.00	0.17	0.17	0.00
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	33.61	1.99	0.99	0.99	0.33	0.33	0.00	0.17	0.33	0.00
paracentral gyrus, adult, pool1	10035-101E8	101.96	7.41	5.22	3.39	4.12	1.19	3.29	2.56	1.83	1.19
parietal cortex, adult, donor10258	10373-105G4	44.04	8.81	0.73	0.00	4.40	0.73	1.47	2.20	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	45.14	5.64	0.94	0.94	1.88	0.00	2.82	0.00	0.00	0.94
parietal lobe, adult, donor10252	10157-103A4	121.43	10.83	7.41	3.42	3.14	0.86	1.71	3.71	0.29	0.57
parietal lobe, adult, pool1	10034-101E7	110.24	5.99	4.49	3.00	4.23	0.79	3.52	1.94	1.76	1.32
parietal lobe, fetal, donor1	10072-101I9	108.62	6.79	0.97	0.97	4.85	13.58	6.79	0.97	0.97	1.94
parietal lobe, newborn, donor10223	10356-105E5	32.90	5.61	0.75	0.00	2.24	1.50	0.37	1.50	0.37	0.00
parotid gland, adult	10199-103F1	156.63	10.48	14.80	7.40	1.85	0.62	0.62	4.93	0.00	1.85
penis, adult	10200-103F2	46.73	2.69	1.07	1.61	0.00	0.00	0.00	0.00	1.61	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	10.97	1.86	0.19	0.00	0.19	1.12	0.00	0.00	0.19	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	84.94	5.68	2.91	2.19	0.58	1.89	0.00	0.15	0.73	0.00
pineal gland - adult, donor10196	10179-103C8	23.22	7.74	0.00	0.00	1.29	0.00	3.87	0.65	0.00	1.94
pineal gland, adult, donor10252	10160-103A7	56.26	5.33	3.55	2.96	1.18	0.59	11.25	1.18	0.00	2.37
pineal gland, adult, donor10258	10377-105G8	31.35	5.02	0.00	0.63	0.63	0.00	5.02	0.63	0.00	3.14
pituitary gland - adult, donor10196	10180-103C9	66.78	7.08	6.07	2.02	1.01	2.02	1.01	4.05	0.00	1.01
pituitary gland, adult, donor10252	10162-103A9	134.46	6.78	13.03	4.17	1.56	0.52	3.13	4.17	2.08	0.52
pituitary gland, adult, donor10258	10378-105G9	46.82	5.11	2.55	0.00	1.70	0.85	1.70	1.70	0.00	0.00
placenta, adult, pool1	10021-101D3	34.29	2.15	2.04	0.86	0.11	0.11	1.51	1.08	0.32	0.32
plasma cell leukemia cell line:ARH-77	10840-111E3	17.35	0.66	0.40	0.26	0.40	0.40	0.00	0.79	0.00	0.00
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	78.29	2.96	0.78	1.25	0.31	0.47	0.00	0.31	0.31	0.00
pons, adult, pool1	10033-101E6	90.03	4.73	5.68	2.93	3.36	0.60	3.96	2.58	2.15	1.03
postcentral gyrus, adult, pool1	10032-101E5	89.97	8.63	4.10	3.40	4.10	0.87	3.05	2.62	2.62	0.70
promyelocytes/myelocytes PMC, donor1	12132-128D8	46.01	8.37	0.00	8.37	2.09	0.00	0.00	2.09	0.00	10.46
promyelocytes/myelocytes PMC, donor2	12136-128E3	99.14	0.00	0.00	0.00	0.00	0.00	11.02	0.00	0.00	11.02
promyelocytes/myelocytes PMC, donor3	12140-128E7	23.47	11.74	0.00	0.00	0.00	0.00	23.47	0.00	0.00	35.21
prostate cancer cell line:DU145	10490-107B4	99.92	7.72	3.79	1.02	1.75	0.29	0.00	1.89	0.00	0.00
prostate cancer cell line:PC-3	10439-106E7	105.82	4.54	3.81	1.82	0.91	0.54	0.00	1.45	0.18	0.00
prostate, adult, pool1	10022-101D4	77.90	2.99	3.26	2.54	0.63	0.82	0.54	1.00	1.45	0.09
putamen, adult, donor10196	10176-103C5	80.97	8.03	1.89	0.94	1.89	0.71	1.18	1.42	0.24	0.47
putamen, adult, donor10252	10152-102I8	156.86	11.76	1.96	3.92	1.96	0.00	0.00	1.96	3.92	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	41.53	3.28	1.09	2.19	0.00	1.09	0.00	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	76.59	9.42	1.93	2.42	2.17	0.72	2.17	1.69	0.24	0.24
putamen, newborn, donor10223	10365-105F5	38.23	6.75	0.00	0.00	3.00	2.25	0.75	0.00	0.00	0.00
rectal cancer cell line:TT1TKB	10469-106I1	19.20	0.58	0.87	0.58	0.29	0.00	0.00	0.29	0.00	0.00
rectum, fetal, donor1	10067-101I4	118.23	11.13	1.39	0.00	0.00	1.39	1.39	0.00	0.00	1.39
renal cell carcinoma cell line:OS-RC-2	10411-106B6	49.18	3.60	1.27	0.85	0.64	1.27	0.00	0.85	0.21	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	20.30	0.41	1.66	0.00	0.41	0.00	0.00	1.24	0.00	0.00
retina, adult, pool1	10030-101E3	63.22	3.08	3.28	2.78	0.80	0.60	0.89	1.49	1.49	0.60
retinoblastoma cell line:Y79	10475-106I7	40.01	2.34	2.86	1.56	0.78	1.04	0.00	2.60	0.78	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	150.98	8.48	1.72	1.72	2.09	5.53	0.00	1.84	0.98	0.00
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	47.52	1.97	0.28	0.28	1.12	0.00	0.00	0.28	0.00	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	72.75	3.79	0.76	0.00	0.00	0.00	0.00	0.00	0.00	0.00
salivary acinar cells, donor1	11771-123I7	54.06	5.66	0.49	0.65	0.49	0.00	0.00	0.49	0.65	0.00
salivary acinar cells, donor2	11772-123I8	50.67	7.71	1.24	1.10	0.83	1.24	0.00	0.55	1.24	0.00
salivary acinar cells, donor3	11773-123I9	13.24	2.65	0.00	1.99	0.66	0.00	0.00	0.00	0.00	0.00
salivary gland, adult, pool1	10093-102C3	76.64	9.72	12.01	2.29	0.57	2.29	3.43	3.43	2.86	3.43
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	47.21	1.01	2.28	0.84	0.84	0.67	0.00	1.10	0.42	0.00
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	46.55	1.76	2.35	0.82	0.24	0.47	0.00	0.71	0.71	0.00
seminal vesicle, adult	10201-103F3	37.56	2.12	1.59	1.59	0.53	0.00	0.00	1.06	1.06	1.59
serous adenocarcinoma cell line:JHOS-2	10639-108I9	28.42	4.86	0.00	0.49	0.24	0.49	0.00	0.24	0.24	0.00
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	98.89	3.02	4.78	2.77	0.25	0.50	0.00	2.77	0.25	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	117.41	7.02	8.03	0.00	2.01	0.00	0.00	3.01	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	53.06	4.43	3.63	3.63	0.81	0.13	0.00	3.09	0.13	0.00
signet ring carcinoma cell line:Kato III	10436-106E4	62.78	2.65	2.98	1.33	0.77	3.43	0.00	1.66	0.33	0.00
signet ring carcinoma cell line:NUGC-4	10483-107A6	49.93	3.87	3.48	0.65	1.03	1.29	0.00	0.65	0.26	0.00
skeletal muscle - soleus muscle, donor1	10282-104F3	15.61	0.00	0.00	0.00	0.00	0.71	0.71	0.00	0.71	0.00
skeletal muscle, adult, pool1	10023-101D5	34.66	1.32	1.20	0.24	0.24	0.24	1.20	0.48	0.48	0.12
skeletal muscle, fetal, donor1	10066-101I3	92.46	10.05	0.00	4.02	0.00	0.00	8.04	0.00	0.00	1.01
skin, adult, donor1	10074-102A2	169.63	6.79	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	138.87	13.89	1.26	0.00	1.26	1.26	0.63	0.63	3.16	1.26
small cell cervical cancer cell line:HCSC-1	10800-110I8	74.38	2.67	4.00	1.33	1.00	4.34	0.00	1.00	0.33	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	122.30	11.03	3.78	0.00	3.15	2.84	25.85	1.26	1.58	0.63
small cell lung carcinoma cell line:DMS 144	10841-111E4	39.13	5.01	1.16	1.16	1.35	0.77	0.00	0.58	0.19	0.00
small cell lung carcinoma cell line:LK-2	10541-107H1	48.29	4.45	3.30	0.99	1.48	2.47	0.00	0.99	0.33	0.00
small cell lung carcinoma cell line:NCI-H82	10842-111E5	32.81	0.64	1.29	0.48	0.64	0.32	0.00	0.32	0.32	0.00
small cell lung carcinoma cell line:WA-hT	10562-108A4	34.43	6.10	4.58	1.74	1.74	1.09	6.97	1.31	0.65	10.90
small intestine, adult, pool1	10024-101D6	34.28	2.63	1.43	3.46	0.36	0.36	0.48	1.31	0.84	0.36
small intestine, fetal, donor1	10064-101I1	59.21	5.16	1.47	1.47	1.72	0.49	1.23	0.49	0.00	0.74
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	15.90	3.59	0.00	0.51	0.00	3.08	0.00	1.03	1.54	0.00
smooth muscle, adult, pool1	10048-101G3	48.59	2.84	0.26	0.26	0.52	0.26	0.52	0.26	2.58	0.00
somatostatinoma cell line:QGP-1	10781-110G7	10.72	0.54	0.54	0.80	0.00	0.00	0.00	0.54	0.00	0.00
spinal cord - adult, donor10196	10181-103D1	219.54	33.03	2.29	1.84	11.47	0.92	2.29	0.92	0.92	0.46
spinal cord, adult, donor10252	10159-103A6	275.99	22.47	8.67	6.70	5.91	0.00	3.55	1.97	1.18	1.97
spinal cord, adult, donor10258	10369-105F9	110.69	14.53	2.77	0.00	5.53	1.38	7.61	0.00	0.00	0.00
spinal cord, fetal, donor1	10056-101H2	340.29	37.20	1.22	2.44	7.93	0.61	6.71	0.61	4.27	1.22
spinal cord, newborn, donor10223	10359-105E8	89.55	16.07	2.76	0.92	3.21	1.38	0.92	0.46	0.00	1.84
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	166.38	16.58	1.49	2.24	3.58	0.90	0.00	1.49	0.15	0.00
spleen, adult, pool1	10025-101D7	54.52	1.76	2.09	2.64	0.00	0.99	0.99	1.10	0.88	1.21
spleen, fetal, pool1	10044-101F8	50.37	1.35	2.30	1.75	0.95	1.35	2.07	1.27	2.30	2.07
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	12.11	1.35	1.04	0.10	0.62	0.00	0.00	0.52	0.21	0.00
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	38.17	2.09	1.52	0.76	0.76	0.38	0.00	0.57	0.19	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	51.37	6.64	0.70	1.75	1.40	0.70	0.00	0.35	0.70	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	14.07	1.95	0.00	0.00	0.39	1.17	0.00	0.00	0.00	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	76.88	3.15	3.94	2.25	2.03	0.45	0.00	2.03	0.34	0.00
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	104.21	9.74	2.54	1.69	1.27	0.42	0.00	3.39	0.42	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	79.54	3.81	1.27	0.42	0.42	0.42	0.00	1.27	0.42	0.00
stomach, fetal, donor1	10062-101H8	82.23	8.54	0.00	0.00	3.20	1.07	0.00	1.07	0.00	0.00
submaxillary gland, adult	10202-103F4	104.82	6.84	6.84	2.28	1.71	0.00	0.57	3.99	2.85	0.57
substantia nigra - adult, donor10196	10178-103C7	162.82	54.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00	54.27
substantia nigra, adult, donor10252	10158-103A5	256.10	15.58	11.01	5.61	4.78	1.04	3.12	5.19	0.42	1.04
substantia nigra, adult, donor10258	10371-105G2	65.69	9.83	5.69	0.52	3.10	0.52	4.66	0.52	0.00	1.03
substantia nigra, newborn, donor10223	10358-105E7	90.44	19.78	2.12	0.00	4.24	0.71	2.12	0.71	0.00	1.41
synovial sarcoma cell line:HS-SY-II	10441-106E9	289.33	13.53	4.13	2.06	4.59	3.67	0.00	3.21	1.38	0.00
temporal lobe, adult, pool1	10031-101E4	91.47	8.65	4.07	2.29	3.90	0.85	3.73	1.44	1.78	0.76
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	73.36	7.12	2.14	1.42	2.85	3.56	4.27	0.00	0.00	0.71
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	43.95	5.27	0.00	0.44	4.83	2.64	2.64	0.88	0.88	0.88
tenocyte, donor1	11763-123H8	294.29	21.64	1.75	3.84	2.79	1.05	0.35	1.40	0.00	0.00
tenocyte, donor2	11765-123I1	156.80	11.83	1.53	1.91	0.76	1.14	0.00	0.00	0.38	0.00
tenocyte, donor3	11768-123I4	201.27	22.98	1.11	1.11	2.59	1.48	0.00	0.37	0.00	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	79.54	5.44	4.08	1.36	1.87	0.85	0.00	1.36	0.68	0.00
teratocarcinoma cell line:NCR-G1	10798-110I6	43.47	6.94	1.08	1.85	2.16	2.16	0.00	0.92	0.92	0.00
teratocarcinoma cell line:PA-1	10807-111A6	42.93	3.41	1.39	0.93	0.93	0.15	0.00	1.24	0.15	0.00
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	52.30	2.79	2.67	1.14	0.51	0.25	0.00	1.78	2.16	0.00
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	27.98	1.89	3.40	0.38	0.38	0.00	0.00	1.51	0.00	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	6.98	0.44	0.65	0.11	0.00	0.00	0.00	0.55	0.33	0.00
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	26.06	0.65	3.91	0.00	0.33	0.65	0.00	1.95	0.33	0.00
testis, adult, pool1	10026-101D8	76.99	4.19	5.80	2.47	3.76	1.07	0.64	1.72	1.61	0.54
testis, adult, pool2	10096-102C6	62.25	6.32	4.96	2.26	4.51	3.16	0.90	3.16	1.35	0.90
thalamus - adult, donor10196	10168-103B6	117.02	9.94	0.00	2.21	2.21	0.00	1.10	0.00	0.00	0.00
thalamus, adult, donor10252	10154-103A1	248.80	17.82	10.47	7.35	5.31	1.56	4.06	3.13	0.78	0.31
thalamus, adult, donor10258, tech_rep1	10370-105G1	53.89	1.54	3.08	0.00	3.08	0.00	1.54	0.00	0.00	1.54
thalamus, adult, donor10258, tech_rep2	10370-105G1	139.82	19.76	1.48	2.31	4.61	0.82	1.81	0.82	0.66	0.33
thalamus, newborn, donor10223	10366-105F6	27.04	4.03	0.58	0.00	0.58	0.00	0.00	0.00	0.58	0.00
throat, adult	10209-103G2	51.18	2.75	2.00	1.00	0.25	0.75	0.75	0.75	1.50	1.00
throat, fetal, donor1	10061-101H7	85.01	10.06	0.61	1.52	1.52	0.30	3.96	0.91	0.61	0.91
thymic carcinoma cell line:Ty-82	10803-111A2	147.66	18.88	2.98	0.99	4.77	8.55	0.00	0.99	0.79	0.00
thymus, adult, pool1	10027-101D9	61.94	3.88	2.09	0.60	2.19	1.39	0.40	0.60	1.09	0.00
thymus, fetal, pool1	10043-101F7	57.36	1.87	1.25	1.25	0.94	1.77	0.31	0.73	3.12	0.52
thyroid carcinoma cell line:KHM-5M	10776-110G2	51.06	3.19	1.99	0.80	0.66	0.93	0.00	1.20	0.13	0.00
thyroid carcinoma cell line:TCO-1	10783-110G9	32.41	1.68	1.26	0.42	0.70	0.42	0.00	0.00	0.00	0.00
thyroid, adult, pool1	10028-101E1	54.68	2.15	6.63	3.64	0.37	0.37	0.00	2.15	0.56	0.00
thyroid, fetal, donor1	10060-101H6	63.81	6.59	1.05	1.58	0.26	0.26	0.26	1.32	0.26	0.00
tongue epidermis (fungiform papillae), donor1	10288-104F9	30.80	0.00	0.00	3.08	0.00	0.00	0.00	0.00	0.00	0.00
tongue, adult	10203-103F5	60.47	7.68	2.33	1.63	0.47	0.00	0.70	0.47	0.47	0.00
tongue, fetal, donor1	10059-101H5	110.35	10.64	1.97	1.18	1.18	0.39	2.76	0.79	0.39	0.39
tonsil, adult, pool1	10047-101G2	52.79	3.61	2.50	1.10	0.80	1.10	0.40	1.20	2.00	0.30
trachea, adult, pool1	10029-101E2	85.23	7.12	3.60	3.44	1.39	0.82	0.98	1.72	1.06	0.57
trachea, fetal, donor1	10058-101H4	137.34	14.23	3.08	3.46	1.54	2.31	1.15	1.92	0.38	1.92
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	165.80	14.17	0.35	0.35	1.42	0.35	0.00	0.35	0.35	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	71.12	7.70	3.75	1.52	2.74	2.33	0.00	2.23	0.81	0.00
transitional-cell carcinoma cell line:JMSU1	10492-107B6	36.19	0.63	0.63	0.47	0.47	0.16	0.00	0.47	1.10	0.00
tridermal teratoma cell line:HGRT	10694-109G1	55.17	13.32	0.00	1.90	0.00	0.00	0.00	1.90	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	65.27	5.42	1.10	1.19	0.42	0.17	0.00	0.42	0.25	0.00
umbilical cord, fetal, donor1	10057-101H3	60.51	12.52	2.09	2.09	0.00	0.00	0.00	2.09	0.00	0.00
uterus, adult, pool1	10100-102D1	55.45	3.41	1.71	1.19	0.34	0.17	0.51	1.37	2.56	1.02
uterus, fetal, donor1	10055-101H1	157.67	9.21	2.56	0.51	0.51	0.51	1.02	0.51	1.02	0.00
vagina, adult	10204-103F6	63.33	2.58	1.94	5.17	0.00	0.00	0.00	0.65	0.00	0.00
vein, adult	10191-103E2	44.72	2.41	1.53	0.44	0.88	0.00	0.44	0.44	0.88	0.00
xeroderma pigentosum b cell line:XPL 17	10563-108A5	15.49	1.87	0.53	0.80	0.80	0.27	0.00	0.00	0.00	0.00